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Cell-cell communication represents a hallmark of multicellular organisms, with that mediated 
by cytokines and their receptors playing important roles in growth, metabolism, homeostasis, 
haematopoiesis and immunity. However, the extent of functional conservation of cytokine 
receptors and related proteins across vertebrates is not clear. The work presented in this thesis 
explored this through the examination of three exemplars of these proteins, cytokine receptor-
like factor 3 (CRLF3), leptin receptor (LEPR) and prolactin receptor (PRLR), using zebrafish 
as a vertebrate model. This involved the pursuit of the following aims: (i) to investigate the 
evolution of CRLF3 and its role in vertebrates; (ii) to determine whether LEPR has a conserved 
function in maintaining energy balance in fish; (iii) to understand the role of PRLR in a non-
mammalian species. 
Chapter 3 identified CRLF3 homologues in a range of early metazoans including placozoa, in 
contrast to archetypal cytokine receptor homologues related to GP130 that are only present 
within bilateria. This demonstrated that CRLF3-related sequences represent the precursor of 
this important protein family. Expression of crlf3 was identified in mesoderm-derived tissues 
in early zebrafish embryos, including the somatic mesoderm as well as anterior and posterior 
lateral plate mesoderm. Later expression was observed in the thymus, brain, retina and exocrine 
pancreas. Two zebrafish crlf3 mutant alleles were generated by TALEN and CRISPR-Cas9 
mediated genome editing. Consistent with the expression of crlf3 in relevant sites in the 
embryo, the crlf3 mutants exhibited significant decreased haematopoietic progenitor cells as 
well as erythroid and myeloid populations during primitive haematopoiesis. In definitive 
haematopoiesis, the crlf3 mutants showed reduced numbers of haematopoietic stem cells, 
erythrocytes, monocytes, neutrophils and thrombocytes, but lymphoid cells were increased. 
The blood of adult crlf3 mutants contained increased numbers of lymphocytes and monocytes 
xiv 
 
but decreased neutrophils and thrombocytes, and in the kidney there were increased 
lymphocytes, monocytes and eosinophils, but decreased neutrophils. No other obvious 
phenotypes were observed in the crlf3 mutants. 
Chapter 4 explored the role of LEPR in zebrafish through generation of two lepr mutants using 
CRISPR-Cas9-mediated genome editing. The lepr mutants showed normal development, 
growth, survival and fecundity, with no significant differences in body mass index (BMI) or 
other metabolic parameters observed in adults. However, overfeeding resulted in a significant 
increase in BMI and fasting glucose of lepr mutants compared to wild-type fish. The lepr 
mutants also showed changes in specific haematopoietic populations in the kidney and spleen, 
but this did not lead to significant changes in blood cell populations.  
Chapter 5 investigated PRLR function through genome editing-mediated generation of mutants 
of the zebrafish paralogue, prlr.a. The prlr.a mutants exhibited normal development, growth, 
fecundity and haematological parameters. In contrast to prl mutants, the prlr.a mutants also 
showed normal survival and swim bladder inflation. However, prlr.a mutants – along with 
stat5.1 mutants – demonstrated a significant reduction in bone formation in hypotonic water 
that could be rescued with high Ca2+ concentration, similar to prl mutants. This suggests a 
Prl/Prlr/Stat5.1 pathway mediates this effect. 
This work has generated new insights into the evolution and functional conservation of 
cytokine receptors. It has demonstrated a relatively subtle role for CRLF3 despite its long 
evolutionary history and shown both conservation and diversification of two other conserved 
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1.1 Cytokines and cytokine receptors 
 
1.1.1 Cytokines 
Cytokines are soluble proteins produced by a diverse group of cells that are usually involved 
in cell-to-cell signalling and regulation of a number of key processes, including cell 
development, proliferation, differentiation, tissue repair, inflammation and immune responses 
(Haddad 2002). Cytokines can be separated into several distinct groups based on structural 
considerations, including the so-called class I and class II cytokines. Despite the primary amino 
acid sequences having little similarity, class I cytokines show structural conservation with a 
conserved bundle of four tightly packed α-helices, while the class II cytokines bear six α-helices 
(Renauld 2003). The class I cytokines contain various interleukins (ILs), such as IL-2, IL-3, 
IL-4, IL-5, IL-6, IL-7, IL-9, IL-11, IL-12, IL-13 and IL-15, as well as granulocyte macrophage 
colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), ciliary 
neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), cardiotrophin-1 (CT), oncostatin 
M (OSM), growth hormone (GH), erythropoietin (EPO), prolactin (PRL), thrombopoietin 
(TPO) and leptin (LEP). The class II cytokines consist of the interferons (IFNs) and the IL-10 
related cytokines (Leonard & Lin 2000). The critical functions of class I cytokines involve the 
regulation of cell differentiation and proliferation mainly of blood and immune cells as well as 
homeostasis, while the class II cytokines are predominantly involved in regulating the immune 
system (Hinck 2010). 
1.1.2 Cytokines receptors 
Typically, cytokines act by binding to specific receptors, known as cytokine receptors, situated 
on the plasma membrane of target cells. Once cytokines are bound to their cognate cytokine 
receptor, intracellular signaling necessary to facilitate the biological effects of each cytokine is 
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initiated (Baker, Rane & Reddy 2007). Haematopoietin cytokine receptors, representing the 
largest cytokine receptor family, comprise of a multi-subunit complex comprising a definite 
ligand-binding chain and a shared signal-transducing receptor chain (Baker, Rane & Reddy 
2007; O'Sullivan et al. 2007). Cytokine receptors possess low sequence homology in the 
extracellular domain, but each consists of a conserved region of around 200 amino acid residues 
known as the cytokine receptor homology domain (CHD), which consists of two fibronectin 
type III (FBNIII) folds with specific class-defining elements (Bazan 1990; Bravo & Heath 
2000). In the class I cytokine receptor chains, the CHD possess two pairs of cysteine residues 
connected by disulfide bonds in the N-terminal FBNIII fold with a conserved WSXWS motif 
in the C-terminal fold (Bazan 1990; Miyajima et al. 1992) (Figure 1.1). Besides the CHD, they 
possess a number of other extracellular protein domains, such as the FBNIII- and 
immunoglobulin (Ig)- like, and a transmembrane domain as well as an intracellular domain that 
is essential for signaling. The intracellular domain holds Box 1 and Box 2 motifs (Ihle et al. 
1995; Taga & Kishimoto 1997), as well as tyrosine residues that become phosphorylated upon 
receptor activation (Baker, Rane & Reddy 2007; Ihle et al. 1995). 
In contrast, although possessing a CHD, the class II cytokine receptor chains have a different 
organization of cysteine pairs with one in each FBNIII fold and crucially lack the WSXWS 
motif (Sato & Miyajima 1994) (Figure 1.1). They have more limited extracellular sequences 
and less intracellular homology, but also possess intracellular tyrosine residues that are 
phosphorylated to initialize cytokine receptor signalling (Baker, Rane & Reddy 2007).  
1.2 Cytokine receptor signalling 
1.2.1 Overview 
Cytokine binding to cognate receptors causes the conformational changes of receptor complex 
that ultimately leads to the activation of intracellular cascades (Firmbach-Kraft et al. 1990; 
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Yamaoka et al. 2004). The first step is the activation of one or more members of the Janus 
kinase (JAK) family that are constitutively situated with intracellular domains of cytokine 
receptor chains (Ihle 1995; Taniguchi 1995). The activated JAKs trans-phosphorylate adjacent 
JAKs and subsequently phosphorylate tyrosine residues that are associated on the receptor 
complex. These mimic as docking sites for the molecules that containing Src homology 2 (SH2) 
domains, which include the dormant cytoplasmic transcription factors commonly known as 
signal transducers and activators of transcription (STATs) (Aaronson & Horvath 2002; Haan, 
Heinrich & Behrmann 2002; Leonard & Lin 2000)  (Figure 1.2). After docking, the STATs are 
also phosphorylated on a tyrosine residue by JAKs and then form homodimers or heterodimers 
via interactions between the phosphotyrosine domains and SH2 residues. These STAT dimers 
are then translocated into the nucleus where they activate the transcription of target genes by 
binding to specific sites in the promoter regions (Leonard & O'Shea 1998; Smithgall et al. 2000) 
(Figure 1.2). Other pathways that can be activated include the phosphoinositide 3-kinase 
(PI3K)/AKT (protein kinase B) and the RAS/RAF/extracellular signal-regulated kinase (ERK) 
pathways. Physiological regulators negatively control cytokine receptor signaling, including 
the suppressor of cytokine signalling (SOCS) proteins (Figure 1.2), protein tyrosine 
phosphatases (PTPs) such as SHP1, SHP2, CD45, PTP1B, and T-cell PTP, and the protein 
inhibitors of activated STATs (PIAS) (Wormald & Hilton 2004). 
1.2.2 JAKs 
JAKs are a non-receptor tyrosine kinases family that consists of four members: JAK1, JAK2, 
JAK3 and tyrosine kinase 2 (TYK2) (Aaronson & Horvath 2002; Yamaoka et al. 2004). These 
large proteins of over 1,100 amino acids (120-140 kDa) possess seven conserved regions 
known as JH1-JH7 (Figure 1.3) (Aaronson & Horvath 2002; Yamaoka et al. 2004). The JH1, 
or kinase domain, is present at  C-terminus and possesses tyrosine kinase activity (Hubbard & 
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Till 2000). The JH2, or pseudo-kinase domain, is structurally similar but devoid of kinase 
activity and plays a significant role in the regulation of the tyrosine kinase domain (Schindler 
& Strehlow 2000). The JH3 and half of the JH4 form a modified SH2 domain that can recognize 
and bind to specific phosphotyrosine residues (Schindler, Levy & Decker 2007). The other half 
of JH4 and JH5-7 represents a FERM domain (radixin, band-4.1, ezrin, moesin) that enables 
contact with cytokine receptors, as well as modulate catalytic activity by binding to the kinase 
domain (Aaronson & Horvath 2002) (Figure 1.3). 
1.2.3 STATs 
STATs are dormant cytoplasmic transcription factor whose activation is required to transduce 
cytokine signals (Takeda & Akira 2000). In mammals, STATs are 750 to 850 amino acid 
residues long transcription factors belong to a family comprised of seven members including 
STAT5A, STAT5B, STAT1, STAT2, STAT3, STAT4, and STAT6 (Kisseleva, Cao & Majerus 
2002). There are six conserved regions in each STAT protein, including the NH2-terminal, 
coiled-coiled, DNA binding, linker, SH2 and transactivation domain (Strehlow & Schindler 
1998) (Figure 1.4). The C-terminal transduction domain is variable between STAT proteins 
and facilitates specific transcriptional responses (Hoey & Schindler 1998; Schindler, Levy & 
Decker 2007). The SH2 domain allows STAT binding via specific phosphotyrosines with 
components of an activated cytokine receptor complex and other STATs, whereas the linker 
domain regulates binding to other proteins or DNA (Kisseleva et al. 2002). The DNA binding 
domain (DBD) facilitates binding to specific sequences in the promoters of responsive genes, 
which is essential for the ability of STATs to regulate transcription (McBride, McDonald & 
Reich 2000). The coiled-coiled domain contributes to protein-protein interactions, receptor 
binding and nuclear export (Strehlow & Schindler 1998). A tyrosine residue which is conserved 
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at C-terminal is phosphorylated by JAKs to facilitate STAT dimerization through interactions 
with  SH2 domain of another STAT (Ward, Touw & Yoshimura 2000).  
1.2.4 The PI3K/AKT pathway 
PI3K activity is induced by recruitment of one of the catalytic subunits, such as p110, to one of 
the SH2-containing adaptor proteins that dock to phosphotyrosine residues of activated 
cytokine receptor complexes, such as p85 (Katso et al. 2001; West, Castillo & Dennis 2002). 
The activated PI3K then acts on the inside of the cell membrane to phosphorylate 
phosphoinositol-2-phosphate (PIP2) to phosphoinositol-3-phosphate (PIP3) (Toker 2000). The 
PIP3 then activates the transcription factor AKT, which can translocate in the nucleus and 
increase the transcription of target genes related to cell growth and proliferation (Datta et al. 
1997; Downward 1998; Engelman 2009). AKT can also bind with BAX and hinder its ability 
to form holes in the outer mitochondrial membrane, thereby inhibiting apoptosis (Toker 2000). 
1.2.5 The RAS/RAF/MAPK pathway 
The RAS/RAF/MAPK pathway is also activated through adaptor proteins like GRB2 and SHC 
that bind to activated receptors via their respective SH2 or phosphotyrosine-binding (PTB) 
domains (Schlessinger 2000). The guanine exchange factor (GEF) son-of-sevenless (SOS), 
which is connected with these adaptor proteins, then facilitates the exchange of RAS-bound 
guanosine 5'-diphosphate (GDP) with guanosine 5'-triphosphate (GTP) thereby activating this 
protein (McCubrey et al. 2007). Activated RAS then activates the RAF kinase, which then 
activates a cascade that ultimately phosphorylates members of the mitogen activated protein 
kinase (MAPK) family, such as the extracellular-regulated kinases (ERK) 1 and 2. The 
activated ERK1 and ERK2 move to the nucleus and activate key transcription factors through 
phosphorylation leading to transcriptional changes (Molina & Adjei 2006). 
  Chapter One: Introduction 
7 
1.3 Class I cytokine receptors 
The class I cytokine receptors can be classified in two ways; either as individual chains grouped 
by structural homology or receptor complexes grouped due to similar functions (Liongue & 
Ward 2007; Sato & Miyajima 1994). 
1.3.1 Structural classification 
By structural homology Class I cytokine receptor chains can be divided into six groups, five of 
which contain CHDs (Figure 1.5). Group 1 receptor chains possess an extracellular domain 
consisting mainly of a CHD, and in the presence of ligand, they form homodimers that are 
sufficient to signal (Boulay, O'Shea & Paul 2003; Heldin 1995). This group includes, for 
example, the growth hormone receptor along with the orphan ‘receptor’ CRLF3, the function 
of which remains unknown (Figure 1.5) (Boulay, O'Shea & Paul 2003). Group 2 receptor chains 
have an extracellular domain with an N-terminal Ig-domain and/or FBN type III domains in 
addition to the CHD, which may be partly or wholly duplicated, along with a transmembrane 
domain as well as a long intracellular domain (Figure 1.5). Group 2 receptor chains can function 
in both ligand binding and signal transduction and often complex with group 3 receptor chains 
(Taga & Kishimoto 1997). Group 3 receptor chains usually have an N-terminal Ig domain along 
with a CHD and are either soluble or possess a transmembrane domain with a short intracellular 
region and typically facilitate specific ligand binding (Figure 1.5) (Boulay, O'Shea & Paul 
2003). Group 4 receptor chains comprise an extracellular CHD domain (or two in IL-3Rβc) 
and a long intracellular domain (Figure 1.5). All function in ligand binding except IL-3Rβc and 
all participate in signal transduction and often in concert with group 5 receptor chains (Boulay, 
O'Shea & Paul 2003). Group 5 receptor chains usually contain an extracellular Ig domain and 
CHD with a intracellular domain which is comparatively shorter (Figure 1.5) (Boulay, O'Shea 
& Paul 2003). These principally function in ligand binding only, except for IL-2Rγc that 
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mediates signal transduction. Finally, although capable of binding to cytokines, the cytokine 
receptor family do not accept the IL-2Rα and IL-15Rα receptor chains as members. Instead, 
these receptors possess alternate sushi domains, which are connected to FBNIII domains, a 
transmembrane domain as well as an intracellular domain (Anderson et al. 1995) (Figure 1.5).  
The extracellular form of the sushi domain commonly known as complement control protein 
(CCP) module or  short consensus repeat (SCR) – has a consensus sequence of approximately 
60 residues that contain four invariant cysteine residues which results two disulfide-bridges (I-
III and II-IV) with conserved tryptophan, glycine, proline, and hydrophobic residues (Reid & 
Day 1989). Structurally, the sushi domain has a hydrophobic core which is small and compact 
with an envelope of six beta-strands stabilised by small and two disulfide bridges (Gaboriaud 
et al. 2000). This domain is also involved in binding of several fragments of complement factors 
including C3b and C4b  (Reid & Day 1989). 
1.3.2 Functional classification 
The functional classification for Class I cytokine receptor complexes groups them by their 
shared or similar signal transducing chains, which generally result in similar downstream 
pathways being activated (Figure 1.6) (Baker, Rane & Reddy 2007). 
1.3.2.1 The hormone/ poietin receptor family 
The receptor complexes of this family include those for growth hormone (GH), prolactin 
(PRL), thrombopoietin (TPO), and erythropoietin (EPO) (Figure 1.6). Each consists of a single 
chain that forms homodimers following ligand binding, which transduces signals intracellularly 
(Baker, Rane & Reddy 2007). EPOR and TPOR function mainly in hematopoiesis, where they 
are essential for the production of erythrocytes and platelets, respectively. In contrast, GHR 
principally regulates growth and also involved in sexual dimorphism (Frank 2001), whereas 
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PRLR mediates the  development of mammary gland and lactation (Bole-Feysot et al. 1998). 
This family of receptors mainly activates JAK2 and STAT5 (Figure 1.6). Although GHR may 
also activate STAT3 and TPOR can also activate Tyk1 STAT1 and STAT 3. Mice lacking 
JAK2 exhibited a block in definitive erythropoiesis as a result of defective EPOR signaling, 
which leads to embryonic lethality at 12.5 day (Neubauer et al. 1998; Parganas et al. 1998). 
Mice lacking STAT5A showed impairment in mammary gland development and lactation due 
to PRLR defects whereas STAT5B knockouts lack sexual dimorphism due to GHR defects (Liu 
et al. 2003). Mice lacked of both STAT5A and STAT5B are infertile because of the incomplete 
copora lutea development in the ovary due to a more severe PRLR defect, as well as anaemia 
because of defective EPOR signaling (Teglund et al. 1998). 
1.3.2.2 IL-6 receptor family 
This family consists of the receptor complexes for IL-6, IL-11, IL-12, IL-23, cardiotropin-1 
(CT-1), ciliary neurotrophic factor (CNTF), oncostatin M (OSM), leukaemia inhibitory factor 
(LIF), leptin (LEP), granulocyte colony-stimulating factor (G-CSF), and GP130-like monocyte 
(GLM) (Figure 1.6). Most members of the IL-6R family use the shared signal transducing 
receptor chain glycoprotein 130 (GP130), and many also employing with the leukemia 
inhibitory factor receptor chain (LIFR), to mediate signal transduction along with a chain that 
is ligand specific such as IL-6Rα. The IL-12R subfamily use complexes consisting of the shared 
receptors, IL-12p40 and IL-12Rβ1, with additional ligand-binding IL-12Rβ1 or IL-23Rα chain. 
Other members of the IL-6R family, obesity gene receptor (LEPR) and granulocyte colony-
stimulating factor receptor (G-CSFR) form homodimers (Devos et al. 1997). Specific receptor 
complexes exert a broad range of functions. For example, IL-6R regulates immune, 
haematopoietic, and a range of other cell types (Ito 2003), IL-12R mediates functions specific 
in innate immunity (Watford et al. 2004), G-CSFR functions in granulocyte development 
(Lieschke et al. 1994), ciliary neurotrophic factor receptor (CNTFR) stimulates the survival 
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and the differentiation of cells in nervous system (Elson et al. 2000) and LEPR plays a vital 
role in appetite control (Tartaglia et al. 1995). Receptor complexes using GP130 or LIFR 
activate JAK1, JAK2, and TYK2 as well as STAT1, STAT3, and STAT5, while LEPR and G-
CSFR activate similar JAKs and STATs (Figure 1.6) (O'Sullivan et al. 2007). In contrast, IL-
12 subfamily of receptor complexes activate more defined downstream components: such as, 
IL-12R specially activates STAT4, whereas IL-23R activates STAT3 (O'Sullivan et al. 2007). 
T cell-specific STAT3 knockout mice had decreased IL-6 dependent proliferation and survival, 
while lymphocytes from STAT4 knockout were unresponsive to IL-12R and not able to 
differentiate into T helper (Th) 1 cells and produce IFN-γ in response to IL-12, and so displayed 
strong Th2 polarization (Imada & Leonard 2000; Kaplan, Wurster & Grusby 1998). 
1.3.2.3 The IL-2 receptor family 
This family contains the receptor complexes for some cytokines such as IL-2, IL-4, IL-7, IL-9, 
IL-13, IL-15, IL-21 and TSLP (Figure 1.6). Member of this family mainly utilizes a common 
receptor chain, IL-2Rγc, for signal transduction, along with receptor chain that is single ligand-
specific, but IL-4Rα and IL-7Rα also produce extra receptor complexes using other receptor 
chains (Ozaki & Leonard 2002). As noted, the IL-2Rα and IL-15Rα chains do not conform to 
the classical class I cytokine receptor chain typology and instead contain distinctive ‘sushi’ 
domains (O'Sullivan et al. 2007). The IL-2R family plays a vital role in growth and maturation 
of lymphoid cells (Gaffen 2001; Parrish-Novak et al. 2000). The archetypal IL-2R plays a vital 
role in the proliferation of T cells with other immunoregulatory functions (Gaffen 2001). IL-
7R functions similar way during T cell homeostasis and T cell development (Fry & Mackall 
2005), IL-4R signaling stimulates the development of Th2 cells whereas IL-21R mediates 
natural killer (NK) cell proliferation and regulates inflammation (Parrish-Novak et al. 2000; 
Paul 1997). The IL-2R family members situiated with JAK1 and JAK3 and primarily activate 
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STAT5, although some family members also able to stimulate STAT1, STAT3, or STAT6 
(Figure 1.6) (Baker, Rane & Reddy 2007; Gaffen 2001). Mice lacking JAK3 knockout 
exhibited a SCID-like phenotype due to impaired response to cytokines using IL-2Rγc (Cao et 
al. 1995; Saijo et al. 1997). Mice with STAT3 knockout showed impaired T cell proliferation 
due to defective IL-2R whereas STAT5A and STAT5B knockout mice had less number of 
natural killer (NK) cells and activated T cells due to defects in IL-2R and IL-15R signaling 
(O'Shea, Holland & Staudt 2013; Yildiz et al. 2015).  
1.3.2.4 The IL-3 receptor family 
This family contains the receptor complexes for granulocyte macrophage colony-stimulating 
factor (GM-CSF), IL-3, and IL-5 (Figure 1.6). The receptor complexes share the IL-3Rβc signal 
transduction chain along with a chain that is ligand-specific (Gearing et al. 1989; Hayashida et 
al. 1990; Itoh et al. 1990; Murata et al. 1992). The main function of the IL-3R family is to 
produce the myelomonocytic cells. IL-3R mediates the differentiation of the pluripotent stem 
cells into several myeloid progenitor cells (Mangi & Newland 1999), whereas the IL-5R is 
engaged in the development of eosinophil (Molfino et al. 2012). IL-3Rβc is linked with JAK2 
and signals mainly via STAT5, although other STAT members are also activated in individual 
cell lines (Rummelt et al. 2015) (Figure 1.6). Mice with deficiency of STAT5A and STAT5B 
in hematopoietic cells possessed a substantially reduced number of peripheral neutrophils and 
were unresponsive to GM-CSF in emergency conditions including myelosuppression (Kimura 
et al. 2009). 
1.4 Cytokine receptor like factor 3 (CRLF3) 
Cytokine receptor like factor 3 (CRLF3) represents a so-called orphan receptor of unknown 
function (Boulay, O'Shea & Paul 2003) that is conserved in vertebrates and divergent from 
other cytokine receptors (Liongue & Ward 2007). 
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1.4.1 CRLF3 gene and protein structure 
The human CRLF3 gene is located on chromosome 17 (Boulay, O'Shea & Paul 2003; Liongue 
& Ward 2007). Structurally, the CRLF3 protein is very simple bearing essentially just a CHD 
with a conserved cysteine pair and WSXWS motif (Figure 1.7). There is no leader sequence 
suggesting different function compared to other members of class I cytokine receptor family 
(Liongue & Ward 2007). 
1.4.2 Expression of CRLF3 
In mouse embryos, Crlf3 was expressed in the thymus, mid brain, sensory organ, genitourinary 
tract, ovary, testis, liver, biliary system and other visceral organs (Smith et al. 2017). In the 
adult mouse, Crlf3 expression was present in the thymus and spleen (Smith et al. 2017). In 
human, CRLF3 has been shown to be highly expressed in appendix, lung, testis, tonsil, and, 
spleen with a moderate level of expression observed in the skin, placenta, endometrium and 
duodenum as well as lower expression in bone marrow, thyroid gland, placenta, pancreas, 
kidney and many other tissues (Uhlén et al. 2015). 
1.4.3 Role of CRLF3 
 No mutation in human CRLF3 have been described and no Crlf3 knockout mice have been 
reported. Knockdown of CRLF3 expression in Tribolium castaneum by RNAi completely 
stopped the neuroprotective effect of EPO in hypoxia-exposed neurons, suggesting CRLF3 is 
required for starting the anti-apoptotic mechanisms in T. castaneum neurons (Hahn et al. 2017). 
Other studies using JAK and STAT inhibitors implicated the JAK-STAT pathway in 
neuroprotection and suggesting that CRLF3 may be upstream of the pathway (Miljus et al. 
2014). The CRLF3 gene was also found to be upregulated during the early cancerous stage of 
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actinic keratosis (AK), in cutaneous squamous cell carcinoma (SCC) and non-melanoma skin 
cancer (NMSC) (Dang et al. 2006). 
1.5 Leptin and leptin receptor 
1.5.1 Leptin 
Leptin (from Greek leptos meaning thin) is a protein synthesized and secreted by white 
adipocytes that plays a vital role in the maintenance of food intake and energy homeostasis 
(Bouloumie et al. 1998). It was first identified in 1994 as the gene mutated in a mouse line that 
exhibited profound obesity characterized by hypothermia, hyperlipidemia, hyperphagia, severe 
adiposity, hyperinsulinemia, and insulin resistance (Muoio & Lynis Dohm 2002). 
1.5.1.1 Leptin gene and protein structure 
The leptin gene, (LEP) also known as Obese (OB), is located on chromosome 6 in mice and 
chromosome 7 in humans and is highly conserved across vertebrates (Houseknecht & 
Portocarrero 1998). Leptin consists of 167 amino acid protein, along with a 21 amino acid 
signal sequence that yields a 16 kDa mature secreted protein (Auwerx & Staels 1998; Tartaglia 
et al. 1995). It is four antiparallel helices combined by two long crossover links with one short 
loop which is arranged in a left-hand oriented twisted helical bundle, and biologically active 
leptin exists in a trimeric form (Zhang et al. 1997).  
1.5.1.2 Leptin expression 
In mouse foetus, leptin expression was observed in the cartilage, hair follicles and in brain but 
in adult it was expressed in adipose tissue, brain, pituitary gland and liver (Flier 1997; Hoggard 
et al. 1997a). In adult rat,  leptin expression was observed in adipose tissue, placenta, and 
stomach (Morash et al. 1999). In rat brain and pituitary, leptin mRNA is selectively transcribed. 
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The expression of leptin mRNA was suppressed by fasting for 48 hr in the hypothalamus, 
highlighting the role of brain leptin in the central regulation of appetite (Morash et al. 1999).  
1.5.2 Leptin Receptor 
Leptin works by its cognate receptor, the leptin receptor (LEPR), also called obese receptor 
(OBR). This plays essential roles in food intake, energy balance and metabolism expressing in 
hypothalamus, midbrain, brainstem and many other different tissues (Elmquist et al. 1998).  
1.5.2.1 Leptin receptor gene and protein structure 
The LEPR gene (LEPR),  also known diabetic (DB) gene is situated on chromosome 4 in mice 
and chromosome 1 in human (Wheeler et al. 2005). The mature full-length LEPR consists of 
816 amino acids with an extracellular portion that comprises two CHD domains (CHD1 and 
CHD2), each preceded by an immunoglobulin-like (Ig) domain, and followed by two 
fibronectin type III domains (FBNIII) (Figure 1.8 A) (White & Tartaglia 1996). The CHD2 
domain plays the central role in the binding of leptin with high affinity whereas the adjacent 
immunoglobulin (Ig) and fibronectin (FBNIII) domains are required for subsequent activation 
of LEPR (Fong et al. 1998; Iserentant et al. 2005; Sandowski et al. 2002; Zabeau et al. 2005). 
This is connected to an intracellular domain by a 23 amino acids transmembrane domain. The 
intracellular portion consists of Box 1, Box 2 and Box 3 motifs, along with three intracellular 
tyrosines at residues 985, 1077 and 1138 (Figure 1.8 A) (Denver, Bonett & Boorse 2011). 
Alternative splicing of the LEPR gene yields at least six different isoforms of LEPR with a 
similar extracellular domain but with variation in the length of the intracellular domain from 
about 302 cytoplasmic residues to 32-40 amino acids (Figure 1.8 B) (Chen et al. 1996; Lee et 
al. 1996), as well as  an additional, LEPR isoform, known as the soluble leptin receptor 
(LEPRe), which consists solely of an extracellular domain (Figure 1.8 B) (Houseknecht & 
Portocarrero 1998).   
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1.5.2.2 Leptin receptor expression 
The long form (LEPRb) was shown to be expressed highly in the hypothalamus in the Arcuate 
(ARC), ventromedial (VMH), dorsomedial (DMH), and ventral premaxillary (PMV) nuclei; 
moderate levels in the lateral hypothalamic area (LHA), and periventricular hypothalamic 
(PVH) nucleus; and lower levels of expression in the paraventricular nucleus (Elmquist et al. 
1998; Mercer et al. 1996a). High levels of long form leptin receptor (LEPRb) is found in the 
thalamus as well as the Purkinje and granular cell layers in cerebellum whereas the short form 
(LEPRa) was expressed within choroid plexus and microvessels of the blood-brain barriers 
(Elmquist et al. 1998; Guan et al. 1997; Lee et al. 1996; Mercer, Moar & Hoggard 1998; 
Tartaglia et al. 1995).  
In the periphery, high levels of LEPRa were identified in kidney, lungs, and lymph nodes, with 
reduce levels in heart, skeletal, white adipose tissue (WAT), spleen, liver, muscle, testes and 
adrenals (Fei et al. 1997; Ghilardi & Skoda 1997; Hoggard et al. 1997b). The LEPRb was also 
expressed in the many tissues such as adipose tissue, kidney, lung, liver, and pancreatic β-cells 
at lower levels (Ghilardi & Skoda 1997; Lollmann et al. 1997). Expression profiles for the other 
isoforms remain poorly defined.  
1.5.2.3 Leptin receptor signalling 
Leptin binding to its LEPR triggers activation of the receptor-associated JAK2 thereby initiates 
the downstream signaling cascade (Nakashima, Narazaki & Taga 1997; White & Tartaglia 
1996). Only in LEPRb does this lead to the phosphorylation of the three tyrosine residues 
(Y985, Y1077 and Y1138) within its intracellular domain (Banks et al. 2000). Adaptor 
molecules can bind the phosphorylated tyrosine residues with SH2 domains (Munzberg 2010). 
Y985 is the docking site for the tyrosine phosphatase SHP2, that facilitates the stimulation of 
the ERK pathway (Munzberg 2010), which play key roles in regulation of growth by promoting 
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transcription of genes such as c-Fos (Banks et al. 2000; Bjorbæk & Kahn 2004). Y1138 is the 
docking site of STAT3, which is involved in the anorexigenic and orexigenic activities of leptin 
and also induces expression of SOCS3, the negative feedback mediator that then suppresses 
JAK2 activity (Bjorbaek et al. 1998; Bjorbak et al. 2000) (Figure 1.9). Activation of the leptin 
receptor also regulates the IRS/PI3K pathway (Figure 1.9) (Fruhbeck 2006).  
1.5.2.4 The biological role of leptin 
Leptin receptor signaling plays a vital role in regulating appetite and metabolism (Denver, 
Bonett & Boorse 2011). It is also involved in regulation of brain size, immune function, blood 
pressure, and neuroendocrine function, sensory nerve input and autonomic outflow, as well as 
adaptive response to fasting. Most of the processes are facilitated centrally, however, some 
other are controlled by signalling in the periphery (Bjorbæk & Kahn 2004). At the molecular 
level leptin signalling controls the expressions of several genes such as SOCS3, c-Fos and the 
genes encoding neuropeptides NPY, AgRP, CART, POMC and TRH in the hypothalamus 
(Bjorbaek et al. 1998; Cheung, Clifton & Steiner 1997; Elias et al. 1999; Kristensen et al. 1998; 
Ollmann et al. 1997; Thornton et al. 1997). Through the stimulation of the gonadotropin-
releasing hormone (GnRH) and gonadotropins from the hypothalamus and adenohypophyseal 
(AP) cells, respectively, leptin supports in the maturation of reproductive axis (Amstalden et 
al. 2005; Chehab et al. 1997). Leptin also regulates the secretion of insulin from pancreatic 
islets (Barzilai et al. 1997; Emilsson et al. 1997), and is involved in the process of bone 
metabolism and bone density maintenance (Mallamaci, Tripepi & Zoccali 2005) by promoting 
progenitor cell differentiation into osteoblasts. Leptin also influences in angiogenesis and 
endothelial cell proliferation and capillary formation (Bouloumie et al. 1998; Sierra-
Honigmann et al. 1998). Leptin has also been implicated in haematopoietic cell proliferation, 
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differentiation and function, and additionally can inhibit the migration of neutrophils in 
response to chemoattractants (Gainsford et al. 1996; Lord et al. 1998; Ottonello et al. 2004).  
1.6 Prolactin and the Prolactin receptor 
 
1.6.1 Prolactin 
Prolactin, a hormone primarily produced from the pituitary gland, was first identified by French 
researchers as a pituitary factor that induces secretion of milk in rabbits and named by American 
scientists as prolactin after showing its involvement in the growth of the pigeon crop (Bole-
Feysot et al. 1998; Gorvin 2015). This hormone is well known for its role in lactation with 
many other proposed functions such as mammary gland development, immune modulation, 
pancreatic islet differentiation, reproduction, osmoregulation, and adipocyte control (Gorvin 
2015). 
1.6.1.1 Prolactin gene and protein structure 
The prolactin (PRL) gene is located on the chromosome 13 in mice and chromosome 6 in 
human (Wheeler et al. 2005). The human prolactin contains 199 amino acids. The secondary 
structure of prolactin showed α-helices with 50% of the amino acid and the rest forms a loops 
in prolactin protein (Freeman et al. 2000).  
1.6.1.2 Prolactin expression 
This protein is mainly produced and secreted by lactotrophic cells of the anterior pituitary 
gland, but it is also expressed  in various parts of brain, normal and malignant breast, lacrimal 
gland, myometrium, circulating lymphocytes, decidua, thymus, lymphoid cell of bone marrow, 
spleen, skin fibroblasts, mammary epithelial cells and sweat glands (Ben-Jonathan et al. 1996). 
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1.6.2 Prolactin receptor 
The diverse roles of PRL are mediated through the wide range distribution of its cognate 
receptor, the prolactin receptor (PRLR) (Foitzik et al. 2003; Garcia-Caballero et al. 1996; 
Nagano et al. 1995; Rivera et al. 2008). The mature protein is anchored in the plasma membrane 
and possesses high affinity for its ligand (Posner, Kelly & Friesen 1975; Posner et al. 1974). 
1.6.2.1 Prolactin receptor gene and protein structure 
The human PRLR gene is located on chromosome 5 and has 10 exons in total spread over 100 
kbp (Arden et al. 1990). Short (S), long (L) and intermediate (I) PRLR isoforms are produced 
due to alternate splicing with differences in the length of cytoplasmic tails (Ormandy et al. 
1998). In addition to these three major membrane-anchored PRLRs, there is another form 
known as soluble PRLR or PRLR-BP generated from primary mRNA by alternative splicing 
or from primary mRNA and/or membrane-bound PRLR by proteolytic cleavage (Amit, Dibner 
& Barkey 1997; Fuh & Wells 1995; Postel-Vinay et al. 1991). 
Full length PRLR consists of an extracellular domain composed of a CHD (Abdel-Meguid et 
al. 1987), a single-pass transmembrane chain composed of 24 amino acids (Goffin, Ferrag & 
Kelly 1998; Kelly et al. 1991) and an intracellular domains contain Box 1 and Box 2 motifs 
(Goffin et al. 2002; Kelly et al. 1991) (Figure 1.10). 
1.6.2.2 Prolactin receptor expression 
The gene encoding prolactin receptor (Prlr) was shown to be expressed in the thymus and spleen 
of adult mouse, while expression was observed in the thymus, lymph nodes, lymphocytes, 
spleen and bone marrow in adult lewis rat (Koh & Phillips 1993). In human the expression of 
prolactin  receptor appeared in the thymus, breasts, pituitary gland, monocytes and T and B 
lymphocytes (Koh & Phillips 1993). 
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1.6.2.3 Prolactin receptor signalling 
Prolactin receptor (PRLR) principally signals via canonical JAK2-STAT5 pathway upon 
binding with PRL ligand (Gouilleux et al. 1994; Liongue et al. 2012) with the activation of 
JAK2  occurring very rapidly after hormonal stimulation (Lebrun et al. 1995). After activation, 
the receptor-associated JAK2 also phosphorylates STAT5 (Figure 1.11) (Goffin et al. 2002). 
The PRL signaling can also activate mitogen-activated protein kinase (MAPK) and 
phosphatidylinositol 3-kinase (PI3K)/AKT pathways (Figure 1.11) (Berlanga et al. 1997; 
Garcia-Martinez et al. 2010; Miller et al. 2005b). 
1.6.2.4 Functions of prolactin and its receptor 
1.6.2.4.1 Mice 
 
Studies on Prlr-/- mice have identified abnormal mammary gland development, during their 
first pregnancy (Goffin et al. 2002; Harris et al. 2006; Hennighausen & Robinson 2008). 
Ablation of Prlr in mice prevents the development of terminal-end buds of mammary gland 
that are important for lactation, which is similar to the phenotype observed in Jak2-conditional 
as well as Stat5a-conventional knockout mice (Harris et al. 2006; Hennighausen & Robinson 
2008; Huang, Snider & Cross 2008). Additionally, during pregnancy PRLR is highly expressed 
in the pancreatic beta-cells and thought to play a role in the expansion of beta-cell to fulfill the 
increased metabolism rate during pregnancy (Arumugam, Fleenor & Freemark 2014). In 
mammals, PRLR is highly expressed in spleen and thymus with expression seen on all 
leukocytes, but its role in the immune response is still controversial (Dogusan et al. 2000). 
Prolactin  has been shown to help T cell activation via CD25, which is essential in the regulation 
of proliferation and expansion of T cell subsets (Takizawa et al. 2005). The presence of 
increased levels of circulating PRL and overexpression of PRLR have been associated in tumor 
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progression and invasion with the higher risk (Peck et al. 2012). Overexpression of PRL and 
PRLR was observed in up to 60% of male breast carcinomas and 95% of female mammary 
tumors (Carver, Arendt & Schuler 2009; Ferreira et al. 2008; Plotnikov et al. 2009). Transgenic 
mice overexpressed prolactin with mammary carcinoma (Wennbo & ToÈrnell 2000). 
1.6.2.4.2 Teleost fish 
Teleosts possess two genes encoding PRL protein, which arose from whole genome 
duplication. One of these, prl.a, is expressed in the pituitary gland like PRL in vertebrates 
(Huang et al. 2009). The zebrafish Prl has been shown to have a fundamental role in 
osmoregulation (Shu et al. 2016). Teleosts including zebrafish also possess two prolactin 
receptor homologs, prlr.a, and prlr.b (Liongue & Ward 2007). In tilapia, goldfish, rainbow 
trout, gilthead sea bream, pufferfish, flounder and Atlantic salmon, prlr is highly expressed in 
osmoregulatory tissues, such as the gill, kidney, and intestine whereas lower levels of 
expression were also observed in the brain, muscle, gonad, liver, lymphocytes, head kidney, 
skin, spleen, and bone of some fish (Dicky et al. 2000; Lee, Kaneko & Aida 2006a; Muller et 
al. 1998). 
1.7 Zebrafish 
The zebrafish (Danio rerio), a member of the Cyprinidae family, is a freshwater fish of sub-
tropical regions found natively in the rivers of Nepal, northern Pakistan, Bhutan, northern India, 
and within South Asia (Bopp, Minuzzo & Lettieri 2006). This fish has characteristic black 
stripes along the body from which its common name is derived. 
  Chapter One: Introduction 
21 
1.7.1 Zebrafish as a model of development and disease 
In the 1980s, the zebrafish was first recognized as a useful research model for investigating 
vertebrate development and disease (Golzio et al. 2012; Panizzi et al. 2012). This is due to 
many favorable properties, including: 
(i) Eggs are fertilized and develop externally, meaning embryos can be examined and 
manipulated from the moment they are fertilized (Hisaoka & Battle 1958).   
(ii)  Embryos develop rapidly, with the overall body plan established within 24 hours (Kimmel 
et al. 1995). 
(iii) Embryos are transparent, so the visualization of cellular and morphological changes is easy 
(Kimmel et al. 1995). 
(iv) Sexual maturity is reached after three to four months and can produce thousands of 
offspring, with a single female able to lay approximately 200 eggs per week (Stern & Zon 
2003). 
(v) Adults are around 3-5 cm in length, and many fish can be maintained in a small facility 
(Kishi et al. 2003). 
(vi) Amenability to physical, biochemical and genetic manipulation (Boch et al. 2009; Kelly et 
al. 2015). 
(vii) Strong conservation to humans concerning key genes important for development and 
disease (Liongue & Ward 2007). 
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1.7.2 Zebrafish resources 
Underpinning the use of zebrafish as a model, many resources have been developed for this 
fish (Strahle et al. 2012). For example, the Zebrafish Genome Sequencing Project of the Sanger 
Institute has played a significant role in sequencing and mapping the zebrafish genome, 
producing mutants and analyzing their characteristics. The Zebrafish Information Network 
(ZFIN) is an online database which provides extensive information regarding genetic, genomic 
and developmental studies of zebrafish, linking relevant information from other research 
organisms (e.g., mouse) and databases of human disease. The National Centre for        
Biotechnology Information (NCBI) also has a wide range of online databases relevant to 
research.  
1.7.3 Zebrafish as a genetic model  
Zebrafish are genetically amenable with forward and reverse genetics approaches used 
extensively (Kari, Rodeck & Dicker 2007). 
1.7.3.1 Forward genetics 
Forward genetic represents an unbiased approach to investigate genes important to defined 
biological phenomena (Consortium 2014). Zebrafish were first analyzed using forward genetics 
approaches, typically using ENU-mutagenesis and screening for phenotypic mutants of interest 
(de Bruijn, Cuppen & Feitsma 2009).   
1.7.3.2 Reverse genetics 
More recently reverse genetic approaches have come to the form, making it possible to 
knockdown or knockout any zebrafish gene to investigate its function. This can be achieved 
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using some different approaches, including morpholinos, transgenic and genome editing 
(Hardy et al. 2010).  
1.7.3.3 Genome editing 
Genome editing methodologies have been widely used in zebrafish to target specific genes 
(Figure 1.12). 
1.7.3.3.1 TALENs 
Transcription activator-like (TAL) proteins consist of an array DNA-binding domains, each 
comprising a 33–35 amino acid repeat, with changes at residues 12 and 13 (known as, variable 
di-residue; RVD) to providing single base-pair specificity (Gaj, Gersbach & Barbas 2013; 
Schornack et al. 2006). These are fused to the type IIS endonuclease, FokI, to form transcription 
activator-like effector nucleases (TALENs) (Campbell et al. 2013; Cho et al. 2013; Christian 
et al. 2010). TALENs are functional as pairs that bind to adjacent sites on genomic DNA, 
enabling the two FokI domains to align to produce double-strand breaks (DSB) (Boch et al. 
2009; Moscou & Bogdanove 2009) (Figure 1.12).  
1.7.3.3.2 CRISPR/Cas9 
 
CRISPR/Cas9 is a genome editing tool that cleaves the genomic DNA by a RNA-guided 
nucleases (Bhaya, Davison & Barrangou 2011; Deveau, Garneau & Moineau 2010; Garneau et 
al. 2010; Horvath & Barrangou 2010; Makarova et al. 2011). Three types (I-III) of CRISPR 
systems are available where each system contains a cluster of CRISPR-associated (Cas) genes 
with noncoding RNAs and a unique arrangement of repetitive elements (direct repeats). Among 
the three systems, the best known system is the type II CRISPR and consists of the Cas9 
nuclease, a guide RNAs encoding CRISPR-RNA (crRNA) array and a necessary auxiliary 
trans-activating crRNA (tra-crRNA) that enables the  crRNA array into distinct units (Gasiunas 
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et al. 2012; Jinek et al. 2013; Magadan et al. 2012). The crRNA and tracrRNA can be merged 
to produce a chimeric, single-guide RNA (sgRNA). Cas9 nucleases mediate strand-specific 
breakage through the conserved nuclease domains, HNH and RuvC (Jinek et al. 2013; Magadan 
et al. 2012) (Figure 1.12).   
1.7.3.3.3 Repair process 
The genomic breaks introduced by TALEN and CRISPR/Cas9 approaches can be repaired by 
either homology-directed repair (HDR) or non-homologous end-joining (NHEJ) (Joung & 
Sander 2013) (Figure 1.12). NHEJ leads to random insertions/deletions (indels) due to errors 
in repair at the cut site, some of which will cause loss of function mutations (Kim et al. 2013). 
Repairing by HDR using an appropriate template facilitates precise changes to be introduced 
(Bedell et al. 2012a; Hockemeyer et al. 2011) (Figure 1.12).  
1.7.4 Zebrafish as a model of cytokine receptor signalling 
Zebrafish show broad conservation of the genes encoding cytokine receptors and downstream 
signaling components (Howe et al. 2013). Zebrafish possess 36 genes encoding class I cytokine 
receptor chains while humans have 33 genes (Liongue & Ward 2007). A majority of genes 
show a 1:1 relationship between zebrafish and humans, but some genes are duplicated in 
zebrafish, including PRLR (prlr.a, prlr.b) (Liongue & Ward 2007), GHR (ghr.a, ghr.b) (Di 
Prinzio et al. 2010), Lifr (lifr.a, lifr.b) (Liongue & Ward 2007; Ogai et al. 2014), CLF1 (clf1.a, 
clf1.b) (Liongue & Ward 2007) and IL12P40 (il12p40.a, il12p40.b) (Liongue & Ward 2007), 
IL2RGC (il2γc.a, il2γc.b) (Liongue & Ward 2007) along with an additional slr gene related to 
PRLR and GHR (Liongue & Ward 2007). Likewise, zebrafish possess no orthologues for 
IL3RA, GMCSFRA, IL5RA, IL3RBC or IL9R in zebrafish (Liongue & Ward 2007). Zebrafish 
also possesses 14 class II cytokine receptor genes compared to 12 in humans (Altmann et al. 
2003; Lutfalla et al. 2003). Again a majority of genes are equivalent between species, with 
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humans having additional IFNLRs, and zebrafish additional genes encoding receptors for 
alternate IFNs (Secombes & Zou 2017).  
Corresponding cytokine genes have also been identified in many cases (Ito 2003). Of relevance 
to this project, zebrafish has two leptin gene paralogues (lep.a, lep.b) (Gorissen et al. 2009), 
two prolactin paralogues (prl.a, prl.b) (Huang et al. 2009), a leptin receptor gene (lepr) (Liongue 
& Ward 2007), a cytokine receptor-like factor 3 gene (crlf3), two prolactin receptor paralogues 
(prlr.a, prlr.b) (Liongue & Ward 2007), two JAK2 paralogues (jak2a, jak2b) (Oates et al. 
1999a), a STAT3 gene (stat3) (Oates et al. 1999b) and two STAT5 paralogues (stat5.1, stat5.2) 
(Lewis & Ward 2004). 
Higher vertebrates have a similar number of cytokine receptors, but are they conserved or have 
they developed specialist functions? The functions of many cytokine receptors have been 
shown to be similar between zebrafish and mammals (Iwanami et al. 2011; Liongue et al. 2009; 
McMenamin et al. 2013; Michel et al. 2016). For example, growth hormone (GH) deficient 
humans have short stature and are mildly obese (Procter, Phillips & Cooper 1998), while the 
zebrafish gh1 mutant, vizzini, exhibit a severe defect in somatic growth and increased adiposity 
(McMenamin et al. 2013). Similarly, granulocyte colony-stimulating factor receptor (Gcsfr) 
knockout mice (Richards et al. 2003) and zebrafish gcsfr mutants are neutropenic (Basheer et 
al. 2019), IL-7Rα deficient humans (Roifman et al. 2000) and zebrafish (Cai et al. 2018) both 
have impaired T lymphopoiesis, while EpoR deficient mice (Lin et al. 1996) and epor ablated 
zebrafish (Paffett-Lugassy et al. 2007) both have defective definitive erythropoiesis.  
However, there are also differences between species. Even mice show differences to humans 
with respect to cytokine signaling. For example, humans have only one IL-3Rβ subunit (hβc) 
gene while mice possess genes for two closely-related proteins (mβc and mβIL-3) with distinct 
functions (Lee et al. 1999). In addition, the IL-2Rγc has different functions in humans and 
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mouse, with a key role in B cell development in the latter that is not evident in humans (Fischer 
et al. 1997; Mestas & Hughes 2004). Zebrafish lacks the genes encoding the IL-3 family of 
cytokines and their corresponding ligand-specific receptor chains (Oltova, Svoboda & 
Bartunek 2018), suggesting other factors are able to functionally substitute, potentially those 
that are duplicated, such as Csf3 (Stachura et al. 2013). Finally, Drosophila possesses a protein 
called Dome, with structural similarities with GP130 in humans (Brown, Hu & Hombria 2001). 
However, the Drosophila protein acts as a homodimeric receptor, with no ligand-specific chains 
like GP130, is activated by 3 ligands compared to 7 in humans and activates a single JAK and 
STAT molecule, compared to the multiple JAK/STAT members used by GP130-containing 
complexes (Brown, Hu & Hombria 2001). Collectively, this indicates some caution was 
appropriate when comparing between species. 
1.8 Project overview 
1.8.1 Rationale 
For all forms of life, there is a necessity to react to external stimuli to survive. Indeed, the 
development and diversification of these signaling systems represent a key driver of the 
evolution of multicellular organisms (Liongue, Sertori & Ward 2016). These systems include 
a wide range of cell surface receptors that activate specific intracellular signaling pathways to 
activate essential target genes to stimulate the desired cellular response; for example, 
proliferation, differentiation, activation, and survival (Boulay, O'Shea & Paul 2003; Liongue, 
Sertori & Ward 2016).  
Although class I cytokine receptors are involved in regulating a great variety of biological 
processes, knowledge regarding cytokine receptor-like factor (CRLF3), despite its conservation 
remains very limited. However, leptin receptor (LEPR) is known to regulate food intake, energy 
metabolism and energy balance in mice and human (Ghilardi & Skoda 1997; Morton & 
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Schwartz 2011) while prolactin receptor (PRLR) is essential in growth, mammary gland 
development, lactation in mammals (Kelly et al. 1991). However, the extent of functional 
conservation remains unknown. Moreover,  
1.8.2 Hypothesis 
Zebrafish represent an excellent model for studying development and diseases with strong 
conservation of key genes, including those encoding cytokine receptors and their downstream 
signaling components (Weyand & Shavit 2014). Based on this, this thesis is based on the 
hypothesis that zebrafish is an appropriate research model to investigate the conserved function 
of cytokine receptors including Crlf3, Lepr and Prlr. 
1.8.3 Aims 
This hypothesis will be addressed by investigating some specific aims: 1) to investigate the 
evolution of CRLF3 and its role throughout the lifespan, 2) to determine whether LEPR has a 
conserved role in maintaining energy balance in zebrafish, 3) to investigate the role of PRLR 
signalling in a non-mammalian species. 
1.8.4 Approach 
This project will include bioinformatics, spatiotemporal expression analysis using whole-
mount in situ hybridization, generation of zebrafish Crlf3, Lepr and Prlr knock-out lines using 
genome editing and functional analysis of these mutant fish using variety of approaches. 
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Figure 1.1: Cytokine receptor homology domains of class I and class II cytokine 
receptors. 
Schematic representation of class I and II CHD, showing the relative positions of conserved 
cysteine (C, thin line) residues and the WSXWS motif (only in class I, thick line). Adapted 
from (Liongue & Ward 2007).  
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Figure 1.2: Cytokine receptor signalling pathways. 
 
Stimulation of a cytokine receptor by ligand binding leads to activation of associated JAK 
molecules that phosphorylate tyrosines located in the receptor complex creating docking sites 
for signalling molecules including STATs. These also become phosphorylated and form dimers 
that then translocate into the nucleus to stimulate the transcription of specific genes. These 
typically include those involved in proliferation, differentiation and survival as well as those 
encoding SOCS proteins that can act with other molecules to negatively regulate signalling. 
RAS and PI3K proteins are also activated to initiate the activation of MAPK and AKT 
pathways, respectively. Adapted from (Vainchenker et al. 2018).  
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Figure 1.3: Structure of JAK proteins. 
 
Schematic representation of JAK protein, showing the seven conserved JAK-homology regions 
(JH1-JH7), which collectively constitute FERM, SH2, pseudo-kinase and kinase domains, as 
indicated. Adapted from (Yamaoka et al. 2004).
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Figure 1.4: Structure of STAT proteins. 
 
Schematic representation of STAT proteins, indicating the positions of the NH2, coiled-coiled, 
DNA-binding, linker, SH2 and transactivation domains and the conserved C-terminal tyrosine 
(Y). Adapted from (Yu & Jove 2004). 
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Figure 1.5: Overview of class I cytokine receptor chains. 
 
Schematic representation of individual class I cytokine receptor chains, divided into six 
structural groups (1-5, Sushi) based on the presence of sushi domains, immunoglobulin-like 
(Ig) domains, cytokine receptor homology domains (CHD), fibronectin type III (FBN) 
domains, transmembrane (TM) domain, and intracellular homology regions (IHR). Adapted 
from (Liongue & Ward 2007). 
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Figure 1.6: Composition of class I cytokine receptor complexes. 
 
Receptor complexes are grouped into the indicated families by functional similarities in their 
signal transducing chains, which leads to similarities in the JAKs and STATs activated and 
downstream biological responses that are initiated. Adapted from (Liongue & Ward 2007). 
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Figure 1.7: Structure of CRLF3. 
 
Representation of CRLF3 showing its variant CHD domain containing a typical pairs of 
cysteine residues (thin lines) and a WSXWS motif (thick line). Adapted from (Liongue & Ward 
2007). 
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Figure 1.8: Structure of the leptin receptor and its isoforms. 
 
A. Schematic representation of the leptin receptor, showing the extracellular domain consisting 
of two immunoglobulin (Ig) domains, two cytokine receptor homology domain (CHD) and two 
fibronectin type III  (FBNIII) domains. This is followed by a transmembrane sequence and an 
intracellular domain with conserved Box 1, 2 and 3 motifs as well as three tyrosine (Y) residues 
that are phosphorylated following receptor activation. Adapted from (Basu et al. 2013). 
B. Schematic representation of the six isoforms of human leptin receptor (LEPRa-f). All 
members possess the same extracellular domain but vary in intracellular domain. Only the long 
form (b), which contains the longest intracellular domain can elicit signaling, while the soluble 
form (e) possesses no transmembrane or intracellular region. Adapted from (Basu et al. 2013).













Figure 1.9: Signalling via the leptin receptor. 
 
Ligand binding causes the activation of JAK2 and phosphorylation of the three tyrosine (Y) 
residues. Y985 activates the ERK 1/2 pathway via SHP2/ MEK1 that induces the transcription 
of c-Fos, and Y1138 activates STAT3 to regulates the energy balance and food intake. The 
negative inhibitor SOCS3 is also activated by STAT3 and can bind Y985 to inhibit JAK2. 
JAK2 can also induce the PI3K pathway that along with STAT3 may play an inhibitory role in 
neuropeptide (NPY) and agouty-related peptide (AgRP) expression. Adapted from (Fruhbeck 





















Figure 1.10: Structure of the prolactin receptor and isoforms. 
 
A. Schematic representation of prolactin receptor (PRLR), showing the extracellular domain 
consisting of a cytokine receptor homology (CHD) domain. There is a transmembrane 
sequence and an intracellular domain with a conserved Box1 and Box2 motifs that are 
phosphorylated following receptor activation. Adapted from (Bernard et al. 2015). 
B. Schematic representation of the four PRLR isoforms (L, I, S, BP). All members possess the 
same extracellular domain but vary in intracellular domain. Only the long form (L) possess the 
whole intracellular domain can elicit signaling, while the soluble form (BP) possesses no 
transmembrane or intracellular region. Adapted from (Bernard et al. 2015).
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Figure 1.11: The prolactin receptor and its downstream signalling via JAK2/STAT5. 
 
Schematic representation of prolactin receptor signalling, showing homodimerization of the 
prolactin receptor following ligand binding activates the intracellular JAK2. This generates 
phosphotyrosine sites for signaling protein such as STAT5, which is itself phosphorylated and 
subsequently translocate to the nucleus to mediate transcription of responsive genes that 
mediate the effect of PRLR. PRLR also activates the RAS/RAF/MAPK and PI3K/AKT 
pathway. Adapted from (Bernard et al. 2015). 
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Figure 1.12: Genome editing tools: TALEN and CRISPR-Cas9 system. 
 
For TALENs (left), the arms of TAL repeats bind to the specific nucleotides at the target site, 
allowing the FokI endonucleases to cut the opposing strand of DNA. For the CRISPR-Cas9 
(right) system, the Cas9 cleave the complementary strands of the target DNA at two active sites 
(RuvC and HNH) and generate a blunt end. The resultant double-stranded breaks (DSBs) are 
repaired by either homology-directed repair (HDR) or non-homologous end joining (NHEJ). 
The NHEJ breakage is repaired by indel (short insertions or deletions) and causes disruption 
or inactivation of target genes selectively. In HDR repair, a homologous donor DNA is 
provided to mediate specific sequence to insert, modification, or deletion sequences at the 
target site. Adapted from (Moore et al. 2012; Terns & Terns 2014).
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The following companies supplied reagents and equipment used in this work: 
Abbott Diabetes care Inc., Doncaster, VIC, Australia 
Ambion, Austin, TX, USA  
Amresco, Solon, OH, USA 
Aquatic Habitat, Boston, MA, USA 
Australian Genome Research Facility (AGRF), Parkville, Vic, Australia 
Australian Biosearch, Wangara, WA, Australia 
Astral Scientific, Sydney, NSW, Australia 
Bioline, Sydney, NSW, Australia 
Bio-Rad, Hercules, CA, USA 
Chem-Supply, Port Adelaide, SA, Australia 
Epicentre, Madison, Wisconsin, USA 
Graph Pad-Prism, Fay Avenue, La Jolla, CA, USA 
GE Health, Little Chalfton, Buckinghamshire, UK 
Gene Search, QLD, Australia 
Gene Target Solutions, Dural, NSW, Australia 
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Gene Tools, Philomath, OR, USA  
Gene Works, Thebarton, SA, Australia 
Gilson, Guelph, Canada 
Integrated Sciences, NSW, Australia 
Interpath Services, Heidelberg West, Vic, Australia 
Leica Microsystems, Buffalo Grove, IL, USA 
Life Technologies, Carlsbad, CA, USA 
Merck Serono Australia Pty Ltd, Forest, NSW, Australia  
MP Biomedicals Australia Pty Ltd, Seven Hills, NSW, Australia 
Olympus, Tokyo, Japan  
Promega, Madison, WI, USA 
Qiagen, Melbourne, Vic, Australia 
Roche Molecular Biochemicals, Indianapolis, IN, USA 
SDR Clinical Technologies, Middle Cove, NSW, Australia 
Sigma-Aldrich, Sydney, NSW, Australia 
Sutter Instrument, Novato, CA, USA 
Thermo Fisher Scientific, Waltham, MA, USA  
The Reef Shop, Deer park, Victoria, Australia 
VWR, Murarrie, Qld, Australia  
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Westlab Group, Ballarat, Vic, Australia 
Zebrafish International Resource Center, Eugene, OR, USA 
2.1.2 Oligonucleotides 
Sigma-Aldrich synthesized oligonucleotide primers with desalt purification for use. 
Table 2.1: List of oligonucleotides. 
 
Primer Description Ori Sequence 5’-3’ bp Application 
AW 024 β-actin F S TGGCATCACACCTTCTAC  18 QRT-PCR, RT-PCR 
AW 025 β-actin R AS AGACCATCACCAGAGTCC  18 QRT-PCR, RT-PCR 
AW 159 M13 F S GTTTTCCCAGTCACGAC 17 Sequencing 
AW 160 M13 R AS CAGGAAACAGCTATGAC 17 Sequencing 
AW 217 SP6 S AATTAGGTGACACTATAG  18 Sequencing 
AW 218 T7 S TAATACGACTCACTATAG
GG  
20 Sequencing 
AW 380 crlf3 F1 S GTTGGTGTAAGGTGGACG
ATGAC 
23 RT-PCR 
AW 381 crlf3 R1 AS AGGTGTGTGAAGGAGCAG
C 
19 RT-PCR 
AW 394 lepr F AS GTCCGAGTTGTTGGCAGA
GAAG 
22 RT-PCR 
AW 598 crlf3 F2 S TTTGTTCTATTGAAAAGG 18 RT-PCR 
AW 599 crlf3 R2 AS CTGCTTCTTGAAGAAA 16 RT-PCR 
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AW 1446 lepr F1  S CCAAAACCATCTCGGCTA
CTGG 
22 RT-PCR 
AW 1447 lepr F2  S ACTCCACCATCCTCCTCTC
C 
20 RT-PCR 
AW 1448 lepr R1 AS GCTTTAGATGGACACTCT
TTCACC 
24 RT-PCR 
AW 1449 lepr R2 AS GAACCTCCATCCAGTGAA
GAAC 
22 RT-PCR 










AW 1462 lepr F3 S TCAGATGTCCTCTCTTGTC
CTCC 
22 RT-PCR 
AW 1463 lepr R3 AS CTCTGAGCCATAAAAACG
ACCTG 
23 RT-PCR 
AW 1464 lepr F4 S CACTGTGATGTCTCGCAA
CG 
20 RT-PCR 
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22 Genome editing 




22 Genome editing 




22 Genome editing 
AW 1478 lepr R4 AS CGTTGCGAGACATCACAG
TG 
20 RT-PCR 




22 Genome editing 
AW 1490 lepr R5 AS TAGTTTGAAATAGAAAGG
TTGGCTCC 
26 RT-PCR 
AW 1491 lepr R6 AS CACCTCTGACTCCTGCGTT
G  
20 RT-PCR 










AW 1619 prlr. a F2 S CACAGTTCAACCGAATAC
TCCG 
22 RT-PCR 
AW 1620 prlr. a R2 AS TCGTATTTATTTTGAACCC
ACCAC 
24 RT-PCR 
  S = sense, AS = anti-sense, bp = base pair, F = forward, R = reverse. 
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2.1.3 Plasmids 
The following plasmids were used in this study. Gene Tools synthesized the TALENs. 
Table 2.2: Plasmids used in this study. 
 
            Description Vector Reference 
 
pA232 spi1 pBK-CMV (Lieschke et al. 2002) 
pA249 lcp1 pSPORT1 (Herbomel, Thisse & 
Thisse 1999) 
pA451 rag1 pCR2.1 (Willett, Cherry & 
Steiner 1997) 
pA455 ikzf1 pBS KS (Willett et al. 2001) 
pA904 crlf3 pGEM-T easy This study 
pA1075 c-myb pGEM-T easy (Soza-Ried et al. 2010) 
pA1104 CRISPR guide RNA empty 
vector 
      pDR274 (Hwang et al. 2013) 
pA1105 Cas9 RNA     pMLM3613 (Hwang et al. 2013) 
pA1197 crlf3 gRNA        pDR274 This study 
pA1201 lepr gRNA        pDR274 This study 
pA1211 tcrα pGEM-T easy (Sertori et al. 2016) 
pA1217 prlr.a TALEN R1     pBK-CMV This study 
pA1218 Prlr.a TALEN L1    pBK-CMV This study 
pA1263 mpo pGEM-T easy (Liongue et al. 2009) 
pA1266 tpor  pGEM-T Easy This study 




2.2.1 In silico methods 
2.2.1.1 Databases 
Databases used for bioinformatics studies were: National Center for Biotechnology 
Information (NCBI) (Wheeler et al. 2005), Ensembl (McLaren et al. 2016) and Zebrafish 
Information Network (ZFIN) (Howe et al. 2012). 
2.2.1.2 Sequence analysis and alignment 
Sequence analysis, manipulation, and assembly were done by the use of sequencer version 
4.10.0 (Gene Codes). Clustal X 2 (Larkin et al. 2007) was used to generate sequence 
alignments, from which trees were generated using the Neighbour-Joining algorithm (Saitou 
& Nei 1987) with replicates of 1000 and viewed with NJ plot (Perriere & Gouy 1996) and Tree 
view 1.6.6 (Page 1998). Synteny analysis was performed with Ensembl (McLaren et al. 2016) 
using version 9 of the zebrafish assembly, version GRCh37 of the human assembly and version 
4 of the fugu assembly. 
2.2.1.3 Primer design 
Oligonucleotides used for polymerase chain reaction (PCR), quantitative real-time PCR (QRT-
PCR), reverse transcriptase polymerase chain reaction (RT-PCR), high-resolution melt 
analysis (HRM) and sequencing were designed using the web program Netprimer. 
2.2.1.4 Guide RNA design 
The potential target sites for the guide RNA (gRNA) of the CRISPR/Cas9 system were 
identified using the ZiFiT Targeter website (Sander et al. 2007), with the following properties: 
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5’-GG-(N)18-NGG-3’ and constrained to using a T7 promoter (Deveau, Garneau & Moineau 
2010). From these corresponding oligonucleotides were designed.  
2.2.1.5 Statistical analysis 
Statistical analyses were performed using Graph Pad Prism (Version 7) software. To determine 
the statistical significance of various treatments, the unpaired independent student t-test was 
employed. The sample populations was maintained of at least 20 embryos and at least 6 adult 
fish. Samples with unequal variance employed the unpaired independent student t-test with 
Welch’s correction. Survival was assessed using the Kaplan-Meier statistical analysis. 
2.2.2 RNA methods 
2.2.2.1 Isolation of total RNA 
Approximately 15-30 zebrafish embryos were used for homogenization with 1 mL Trizol 
reagent (Life Technologies) and separated into phases with 200 μL of chloroform. The RNA 
was extracted from the aqueous phase and precipitated by the addition of 500 μL isopropanol 
and incubation for 10 min at room temperature. The RNA was pelleted by centrifugation at 
12,000 g for 10 min at 4°C, before being washed in 75% (v/v) ethanol as well as centrifuged 
at 7,500 g for 5 min at 4°C. The air-dried RNA was homogenously resuspended with 30 μL of 
sterile nuclease-free water (Amresco). 
2.2.2.2 Digoxigenin-labeled RNA 
For in situ hybridization, digoxigenin (DIG)-labelled RNA was produced using 500 ng 
linearized plasmid DNA or PCR products with 2.0 µL 10 × DIG labeling mix, 2.0 µL10 × 
Transcription buffer, 1.0 µL RNase inhibitor (20 U/µL), 2.0 µL T7 (20 U/µL) or SP6 (20 U/µL) 
polymerase (Roche, Molecular Biomedical), and sterile nuclease-free water (Amresco) was 
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added to adjusted the volume to 20 µL. After incubation at 37°C for 2 h, the DNA template 
was destroyed by using 2.0 µL of DNase I (10 U/µL) and incubated at 37°C for 15 min. Finally, 
2.0 µL of 0.2 M EDTA (pH8.0) was used to terminate the reaction. 
The G-50 gel filtration exclusion microcolumns (GE Health) was used to purify the RNA. The 
column was prepared by brief vortexing followed by centrifugation at 735 g for 1 min. The 
labeled RNA was then applied to the column which had been placed in a sterile 1.5 mL 
eppendorf tube and centrifuged at 735 g for 2 min. The purified RNA was then stored at -20°C.  
2.2.2.3 Agarose gel electrophoresis 
RNA electrophoresis was performed using a Formaldehyde-Free RNA Gel Kit (Amresco). 
Gels were prepared with 1.2% (w/v) agarose and 1× Formaldehyde-Free RNA Gel Solution 
according to the manufacturer’s instructions. SYBR safe (1:10000) (Life Technologies) was 
added to enable visualization of RNA. These gels were subjected to electrophoresis in 
Formaldehyde-Free RNA Gel Running Buffer at 100-110 V for 30 min. 
2.2.3 DNA methods  
2.2.3.1 Reverse transcription 
To generate cDNA, the iScript cDNA Synthesis Kit (Bio-Rad) was used. Briefly, 500 ng total 
RNA was added to 4 µL 5 × iScript Reaction mix and 1 µL iScript Reverse Transcriptase 
(U/µL) and the volume adjusted to 20 µL with sterile nuclease-free water (Amresco). Then it 
was incubated at 25°C for 5 min and then 42°C for 30 min for generation of the cDNA and 
85°C or 5 min to denature the reverse transcriptase. 
                                                                                            Chapter Two: Materials & Methods  
62 
2.2.3.2 Reverse transcription-polymerase chain reaction 
A PCR reaction containing 12.5 µL GoTaq mix (Promega) was used for a 2 µL aliquot of 
cDNA. 2.5 µL of each primer (10 µM) was added and the final volume was adjusted to 25 µL 
with sterile nuclease-free water (Amresco). At the beginning, a typical PCR conditions used 
94°C for 2 min as a denaturation step, followed by 35 cycles of 94°C for 1 min, 58°C for 1 
min, 72°C for 2 min, and finally 72°C for 10 min. These typical conditions and cycle numbers 
were modified as necessary. 
2.2.3.3 Agarose gel electrophoresis 
DNA electrophoretic analysis was performed using 1-3% (w/v) agarose gels containing 1× 
TAE buffer (40 mM Tris-HCl, 190 mM glacial acetic acid, 10 mM EDTA; pH 8.0) and 0.006% 
(v/v) SYBR Safe (Life Technologies). These gels were subjected to electrophoresis in 1× TAE 
at 100-110 V for 30-40 min before visualization under UV. 
2.2.3.4 DNA purification 
The QIA quick PCR purification kit (Qiagen) was used to purify the PCR products, following 
the manufacturer’s instructions. The QIA quick gel extraction kit (Qiagen) was also used to 
purify the DNA fragments from agarose gels following the manufacturer’s protocol, with 
variation at step 13 such that the DNA was eluted with 30 µL nuclease-free water (Amresco). 
2.2.3.5 Restriction enzyme digest 
Plasmid DNA (typically 1-2 μg) was digested using the required restriction endonucleases 
(Roche) for 2 h, following the manufacturer’s directions for incubation temperature and buffer. 
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2.2.3.6 Plasmid purification 
A Wizard Plus Minipreps DNA Purification System Kit (Promega) was used to prepared 
plasmid DNA, following the manufacturer’s recommendations. The protocol was varied in 
centrifugation at steps 1 (4,000 g for 5 min), as well as steps 5 and 9 (12,054 g) and step 14 
where nuclease-free water (50 µL) was used to elute the DNA at 12,054 g. Midipreps was 
performed by using Invitrogen Purelink Plasmid Midiprep kit (Life Technologies) following 
the manufacturer’s recommendations. 
2.2.3.7 DNA sequencing 
DNA sequencing was done with double-stranded plasmid DNA or PCR products of 100-1000 
bp. Reactions contained 3-75 ng template DNA and 0.83 µM oligonucleotide primer in 12 µL 
adjusted with sterile nuclease-free water (Amresco) and were analysed by Sanger sequencing 
methods in Australian Genome Research Facility (AGRF). 
2.2.3.8 Production of gRNA and Cas9 mRNA 
The gRNA expression vectors were digested by DraI which was used as templates for 
transcribing sgRNAs by using MEGA short script TM kit (Life Technologies). The Cas9 
plasmid, pMCM3613 (Addgene) was linearized using PmeI enzyme and transcribed using the 
mMESSAGE mMACHINE T7 ULTRA Kit (Life Technologies). The sgRNAs and Cas9 
mRNA were purified using the MEGA clear TM Kit (Life Technologies). 
2.2.3.9 High resolution melting  
High Resolution Melting (HRM) was done on DNA extracted from whole 4 day post 
fertilization (dpf) embryos or tail fin from adult fish using Precision Master Mix (Bio-Rad) on 
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a Bio-Rad CFX96 thermocycler, and analyzed by using Bio-Rad Precision Melt CFX Manager 
Software. 
2.2.3.10 Genomic DNA extraction  
Fin clips from embryos or adult zebrafish were placed in 30 μL Quick Extract solution 
(Epicentre) and the samples incubated at 68°C for 2 min before vortexing for 30 sec and 
incubating at 98°C for 2 min. Samples were again vortexed for 30 sec and then centrifuged at 
12,054 g for 5 min at 4°C. 
2.2.4 Cloning methods 
2.2.4.1 Bacterial strains and media 
E. coli strain XL 10-Gold (Biolab) endA1 glnV44 recA1 thi-1 gyrA96 relA1 lac Hte 
Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 F'[proAB lacIqZΔM15 Tn10(TetR Amy CmR)] was 
used for plasmid propagation. Clones were grown in 2 × YT medium (1.6% (w/v) tryptone, 
1.0% (w/v) yeast extract, 0.5% (w/v) NaCl) with appropriate antibiotic (typically 100 µg/mL 
ampicillin), for selection of plasmids.  The solid media contained agar of 1.6% (w/v). 
2.2.4.2 Competent cells 
XL 10-Gold cells were grown in 50 mL LB at 37°C with shaking at 200 g until OD600 reached 
0.3-0.6. Cultures were harvested by centrifugation at 4,000 g for 20 min at 4°C. The supernatant 
was removed and the pellet was resuspended in 15 mL of ice-cold buffer RF1 (160 mM KCl, 
50 mM MnCl2.4H2O, 30 mM CH3CO2K, 10 mM CaCl2.2H2O, 15% (v/v) glycerol) at pH 5.8. 
Suspension was incubated on ice for 15 min and centrifuged at 4000 g for 10 min at 4°C. The 
pellet was resuspended in 5 mL ice-cold buffer RF2 (0.5 M MOPS, 20 mM KCl, 70 mM 
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CaCl2.2H2O,15% (v/v) glycerol) and incubated on ice 15 min. After this, the cells were 
aliquoted (100 µL) and quickly frozen by dipping in liquid nitrogen and stored at -80°C. 
2.2.4.3 Ligation and transformations 
Linear PCR products were ligated using the pGEM-T secure vector system (Promega) 
following the manufacturer’s recommendations and using a 2:1 ratio of DNA:Vector and an 
overnight incubation at 4°C. Alternatively, oligonucleotides for gRNA were annealed in a 
thermocycler (95°C for 1 min, then decreasing 1°C every 30 sec until 4°C) and cloned into 
pDR274. Competent XL 10-Gold cells were collected from the -80oC freezer and kept on ice 
for thawing. An aliquot of 2-5 µL of the ligation solution was added to 100 × of competent 
cells and kept for incubation on ice for a further 15 min and finally a heat-shock was done for 
45 sec at 42oC which was terminated by placing the tube on ice for 3 min. Following this, a 
pre-warmed 800 µL aliquot of 2 × YT broth was added, and the cells were incubated with 
shaking at 37°C for 1 h at 200 g. Cells were plated onto 2 × YT plate media containing 
appropriate antibiotic with 30 mg/mL (5-bromo-4-chloro-3-indolyl β-D-galactopyranoside (X-
gal)) as required, and were incubated overnight at 37°C and visually screened for blue/white 
colonies when necessary. 
2.2.5 Zebrafish methods 
2.2.5.1 Fish maintenance and embryo collection 
Adult zebrafish were maintained in an Aquatic Habitats aquarium system at 28.5°C on a 14 
h/10 h light/dark cycle and fed three times daily. The embryos were manually spawned and 
maintained in a petri dish that containing aquarium water with 0.00005% (w/v) methylene blue 
(Sigma-Aldrich) and raised in an incubator at 28.5°C. Aquarium water containing 0.03% (w/v) 
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1-phenyl-2-thio-urea (PTU) was used at 8 h post fertilization (hpf) to inhibit pigmentation to 
enhance embryo transparency. 
At appropriate time points embryos were collected and anesthetized with 0.4 mg/mL 
benzocaine and finally fixed with 4% (w/v) paraformaldehyde (PFA) made in phosphate-
buffered saline (PBS). All experiments were accomplished under the Deakin University 
Animal Welfare Committee guidelines. 
2.2.5.2 Microinjection 
Injection needles were drawn on a Flaming brown micropipette puller model P-87 (Sutter 
Instruments) where a heat setting of 339, pull 45, velocity 80 and time 150, was used from a 
1.0 mm capillary (SDR Clinical Technologies), and then bent by flaming. The needles were 
loaded using pipette tips with Cas9, guide or TALEN RNAs with 1% (w/v) phenol red. 
Mounting of needles were done in a Narishige MN-151 micromanipulator which was attached 
to a Nikon SMZ 645 dissecting microscope. The one-cell stage embryos of zebrafish were held 
with watchmakers’ forceps, and the needle positioned so as it entered the cell. For each embryo, 
~2 µL of a solution prepared with 12.5 ng/μL of gRNA and ~300 ng/μL of Cas9 mRNA was 
used for injection. Typical injection conditions had a pulse duration of 0.3 sec with a gas 
pressure of 400 kPa. After injection, embryos were subsequently allowed to develop in an 
incubator set to 28°C.  
Morpholinos were designed and ordered from Gene tools. Then injected into one to eight-cell 
stage embryos as a diluted form 0.5-2 mM concentrations. The level of gene knockdown was 
determined by RT-PCR, compared to those injected with standard control morpholino at the 
equivalent concentration. 
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2.2.5.3 Inhibitor treatment 
Embryos were collected and placed in system water with 0.03% PTU, which was replaced with 
the same solution containing 30 µM JAK3 inhibitor or DMSO as control from 2 to 7 dpf before 
fixing with 4% PFA. 
2.2.5.4 O-dianisidine staining 
For staining, embryos were euthanized and incubated in 0.5 mg/mL O-dianisidine (Sigma-
Aldrich) in 40% (v/v) ethanol, 6% (v/v) H2O2 (BDH) and 0.01 M NaOH for 15 min in the dark, 
and finally fixation in 4% PFA/PBS after 3 × 5 min PBS-T washes. 
2.2.5.5 Embryo fixation 
Embryos were fixed in 4% (w/v) paraformaldehyde (PFA) prepared in phosphate buffered 
saline (PBS) containing 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO, 1.47 mM KH2PO4 
(PFA/PBS) after euthanization using 0.4 mg/mL benzocaine (Sigma-Aldrich). After fixing 
embryos were stored for at least 1 day at 4°C. Storage for long-term, embryos were dehydrated 
with 100% (v/v) methanol and kept at -20°C. 
2.2.5.6 Whole mount in situ hybridization (WISH) 
Fixed embryos were rehydrated by using a series of 5 min washes with different concentration 
of methanol such as 50% (v/v) methanol, 30% (v/v) methanol and PBS-T (PBS plus 0.1% 
Tween-20). Refixation was done for 20 min in 4% (v/v) PFA/PBS followed by 3 washes in 
PBS-T. Older embryos (more than 26 hpf) were incubated in PBS containing proteinase K at 
room temperature, 24-36 hpf with 10 µg/mL proteinase K and 36 hpf-10 dpf with 20 µg/mL 
proteinase K for 10 and 30 min, respectively. Digoxigenin-labeled antisense RNA probes were 
used for hybridization. Embryos were incubated in 500 µL of HYB- (50% (v/v) formamide, 5 
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× sodium chloride/sodium citrate (SSC), 0.1% (v/v) Tween-20) for 5 min at 70°C and replaced 
with 500 µL of HYB+ (HYB- containing 5 mg/mL ribonucleic acid, 0.05 mg/mL heparin 
(Sigma)) at 70°C for at least 3 h. Embryos were bathed in 300 µL of probe solution (1/50–
1/300 dilution in HYB+) and incubated at 70°C overnight. Probes solutions were removed 
following the incubation, and the washing of embryos was done in 50% (v/v) formamide / 2 × 
SSCT for 30 min and 60 min at 70°C. The washed embryos were further washed for 15 min in 
2 × SSC-T and 2 × 15 min washes in 0.2 × SSC-T also at 70°C. Finally, washes in PBS-T was 
done for 3 × at room temperature before incubating in blocking solution (0.02% (w/v) bovine 
serum albumin (BSA), 5% (v/v) fetal calf serum (FCS) in PBS-T) for 2 h at room temperature. 
Following this, embryos were bathed into blocking solution with (0.15 U/μL) of alkaline 
phosphatase (AP) conjugated anti-DIG antibody (Roche, Molecular Biochemicals) at 4°C 
overnight. After incubation, embryos were washed in PBS-T for 6 × 15 min with gentle rocking 
at room temperature and 3 × 5 min in staining buffer containing 0.1 M Tris pH 9.5, 0.05 M 
MgCl2, 0.1 M NaCl, 0.1% (v/v) Tween 20 with 25 μg/mL levamisole. Finally, staining of 
embryos were performed in staining buffer containing 0.225 mg/mL nitro blue tetrazolium 
(NBT) and 0.175 mg/mL 5-bromo,4-chloro, 3-indolyl phosphate (BCIP) at room temperature 
in the dark for 4 h to 3 d, but normally overnight. After appropriate extent of staining, embryos 
were finally rinsed in PBS-T and fixed in 4% PFA/PBS. High resolution WISH was also 
performed where appropriate with additional washes with several variations in few steps 
briefly, replacing the HYB+ and HYB- with HM+ and HM-, fetal serum with sheep serum in 
blocking solution and pre absorption of the antibody with wild-type fixed fish (500 embryos 
for 10 mL 1:1000 diluted antibodies). 
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2.2.5.7 Haematopoiesis analysis 
Blood was collected from 5 dpf embryos by fin transection and from adults by tail transection 
and resuspending in PBS supplemented with 2 mM EDTA containing 2% FCS. Adult kidneys 
and spleens were dissected and resuspended in PBS containing 2 mM EDTA and 2% FCS. The 
cells were placed on slides using a cytospin funnel (Thermo Fisher Scientific), with 
centrifugation at 750 g for 5 min. Fixation of slides were performed in 100% methanol for 1 
min. The staining was done by incubating the slides in Giemsa for 20 min. Slides were observed 
on a Leica DME stereomicroscope and differential counts performed. 
2.2.5.8 Imaging 
Embryos were visualized using an MVX10 microscope (Olympus) with stage lighting provided 
using LG-PS2 fiber optics light source (Olympus). The digital images wave recorded using 
Cell Sens Dimension 1.6 software (Olympus) and DP72 camera (Olympus). Using the DFC290 
digital camera (Leica) maintained by the Leica Application Suite for Windows (Leica 
Microsystems) images of stained slides were captured. Adult fish were imaged with a camera 
of mobile (Samsung Note 4) next to a slide with a cm scale. 
2.2.5.9 Feed trial 
At 3 month post fertilization (mpf), the adult zebrafish were kept in two dietary groups called 
overfeeding and restricted groups, with seven fish per 3-L tank. Fish in the overfeeding group 
were fed with freshly hatched Artemia (equivalent to 60 mg cysts/fish/day) three times per 
weekday and two times on the weekend (Oka et al. 2010). Fish of restricted group were fed 
three times per weekday and two times on the weekend with freshly 
hatched Artemia (equivalent to 5 mg cysts/fish/day) (Oka et al. 2010).  
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2.2.5.10 Body measurement  
The body and jaw of juvenile fishes were measured after PFA fixation imaging by an MVX10 
microscope (Olympus) next to a ruler. Adult fish were after anesthetized with benzocaine, dried 
gently with a paper towel, and then weighed and imaged with a ruler to determine the length.  
BMI of each fish was calculated from the weight and length of each fish using the formula 
((weight in g / (length in cm) 2). 
Zebrafish embryos were kept in water prepared with Instant Ocean salts (IOS). Freshwater 
(FW) was used as egg water (60 mg/L IOS) for early stages (<6 dpf) and regular system water 
(175 mg/L IOS) for juvenile and adult stages. Swim bladder inflation was assessed under a 
light microscope at 9 dpf (Shu et al. 2016).  
For bone staining, the fertilized eggs were maintained in fresh water (salinity: 60-175 mg/L), 
hypotonic water with lower concentration of calcium (HWLC) (sanility: 675 mg/L, Ca2+: 
71.68 mg/L) and hypotonic water with high concentration of calcium (HWHC) (sanility: 
675 mg/L, Ca2+: 143.36 mg/L) (Shu et al. 2016). The juveniles were collected at 11 dpf stage, 
and ethically culled and fixed in 4% PBS at 4°C for overnight and stained in freshly prepared 
1.52 µg/mL Alizarin red (Sigma-Aldrich) in KOH (5 M). The fixed juvenile were rinsed with 
1× PBS for three times. Staining was done with freshly prepared 1.52 µg/mL KOH alizarin 
solution for overnight at RT with rocking (Shu et al. 2016). The juveniles were washed briefly 
with 1× PBS before being photographed with a microscope MVX10 (Olympus) and preserved 
in glycerol at 20°C. 
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2.2.5.11 Survival assay 
The embryonic survival assay was done by counting the embryos from one day to seven days 
and analyzing the survival rate. In the case of adult fish, the survived fishes were counted by 
weekly based from one week to 12 weeks and analyzed by the Kaplan Meier statistical analysis.  
2.2.5.12 Mating and fertilization assay 
The fecundity of adult fish was analysed by mating success and fertilization success. For this, 
three couples were set up for mating three times with each successful mating recorded. The 
fertilization success was analysed by the percentage of fertilized eggs at 1 dpf. 
2.2.5.13 Blood glucose level measurement 
Adult fish were anesthetized, and the head transected just after the pectoral fin to obtain a drop 
of blood for analysis using a Freestyle lite blood glucose analysis machine (Abbott Diabetes 
Care Inc.).  
2.2.5.14 Fin clipping 
Individual zebrafish were anthesized by placing in aquarium water containing 20 μg/mL 
benzocaine, then transferred to a glass slide, with the tip of the tail fin amputated with a number 
10 scalpel blade and placed into a microcentrifuge tube on ice. The zebrafish were transferred 
to aquarium water to recover. 
2.2.5.15 Dissection of adult zebrafish 
Adult fish were euthanized with benzocaine (50 μg/mL) overdose and dissected with a 
biological dissecting tool to collect the kidney, spleen, liver and white fat for further analysis. 
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2.2.5.16 Blood clotting assay 
Zebrafish embryos at 5 dpf were injured with a 15 μm glass needle by puncturing the blood 
vessel near the tail region, and the time required to stop the resulting bleeding observed under 
the microscope. For adult fish, anaesthetized fish were transected in the caudal region with a 
scalpel blade with the time required for clotting observed under the microscope.  
























Cytokines and their specific receptors are a key component of cell-to-cell communication in 
multicellular organisms (Liongue, Sertori & Ward 2016). Together they play significant roles 
in immunity as well as other developmental and homeostatic processes (Robb 2007).          
Cytokine receptors are complex proteins with a number of different domains, but all share a  
cytokine receptor homology domain (CHD) consisting of two fibronectin (FBN) type III folds 
bearing one or two paired cysteine with or without a WSXWS motif depending on whether it 
is a Class I or Class II receptor (Liongue, Sertori & Ward 2016). Higher vertebrates possess a 
CRLF3 protein, which consists solely of a class I-type cytokine receptor homology domain 
(CHD), and a large family of cytokine receptors which possess one or more class I-type  CHD, 
along with additional extracellular domains as well as a transmembrane and intracellular region 
typified by GP130, as well as a variety of receptors containing class II type CHDs (Liongue & 
Ward 2007).  The urochordate sea squirt (Ciona intestinalis) possesses proteins related to Crlf3 
and GP130. Protostomes such as fruit fly (Drosophila melanogaster) possess a GP130 
homologue called Domeless, which acts as a classical cytokine receptor (Liongue & Ward 
2007). However no Crlf3 homologue was identified in the fruitfly, suggesting it might be 
vertebrate-specific and that the common ancestor of DOME and GP130 represented the 
archetypal cytokine receptor that subsequently expanded to generate the extensive cytokine 
receptor family in the vertebrates (Liongue & Ward 2007).  
Understanding of the role of Crlf3 remains rudimentary, with no published human mutation or 
mouse knockout. One study has reported involvement of Crlf3 in synaptic vesicle biogenesis 
(Hashimoto et al. 2012), while another suggested it is upregulated in skin cancer (NMSC) 
(Dang et al. 2006). Some information regarding Crlf3 expression in mouse and human is also 
available on-line (Smith et al. 2017; Uhlén et al. 2015). 
                                                                               Chapter Three: Crlf3 evolution and function  
75 
This Chapter aimed to identify the evolutionary history of Crlf3, as well as to characterize 
zebrafish crlf3, investigating its embryonic expression and function in growth, development 
and haematopoiesis in zebrafish. 
3.2 Evolutionary analysis 
 
To further investigate the hypothesis that Crlf3 was specific for vertebrates, other 
representative protostome species were examined. Unexpectedly, this identified a Crlf3 protein 
homologue in the red flour beetle (Tribolium castaneum), which grouped with the vertebrate 
Crlf3 sequences (Figure 3.1 A and B), indicating that both GP130 and Crlf3 related protein 
were present at the divergence of protostomes and deuterostomes. Having established that 
bilaterians possessed molecules related to both GP130 and Crlf3, early metazoan genomes from 
ctenophores, porifera, placozoa and cnidaria, with those from choanoflagellates and 
amoebozoa, were searched for the potential CHD domain containing proteins. None were 
found within the amoebozoa, choanoflagellate, ctenophore or porifera. However, a single 
homologue was found in placozoa (Trichoplax adhaerens) and cnidara (Nematostella 
vectensis) which formed a clade with other Crlf3 sequences that distinct from GP130 and 
related sequences (Figure 3.1 A and B). Alignment of the Crlf3 proteins from these species 
indicated moderate conservation across the entire protein, including the absence of leader 
sequences which are required to target the protein to the cell membrane for tethering or export 
(Figure 3.1 C). Synteny analysis of human CRLF3 and zebrafish showed conservation of a 
syntenic relationship with SUZ12A-related genes (Figure 3.1 D). Collectively, this indicates 
that Crlf3 and its constituent CHD is ancient and further suggests a conserved evolutionary 
function for Crlf3 given the very long-time frame over which it has been maintained. 
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3.3 Expression analysis of zebrafish crlf3 
 
Expression of crlf3 during zebrafish embryogenesis was examined by whole-mount in situ 
hybridization (WISH).  Embryos were obtained at key time points throughout development and 
subjected to hybridization with full-length anti-sense RNA probe specific for crlf3, compared 
to embryos hybridized to control sense probe. Distinct expression of the crlf3 gene was first 
evident from 10 hpf in the developing somites (Figure 3.2 B) which continued until 18 hpf 
(Figure 3.2 D-G). Bilateral stripes of expression were observed from 12 hpf in the anterior 
lateral plate mesoderm (ALM) (Figure 3.2 C) and posterior lateral plate mesoderm (PLM) 
(Figure 3.2 D), the latter representing the site of common blood and vascular precursors, which 
continued to 18 hpf (Figure 3.2 F-G), and at 20 hpf in the pronephric ducts (PNDs) and 
posterior intermediate cell mass (pICM) (Figure 3.2 H). Embryos injected with a lycat antisense 
morpholino, which ablates haematopoietic progenitors (Xiong et al. 2008), showed no crlf3 
expression in the PND or pICM (Figure 3.2 I) compared to those injected with standard control 
morpholino (Figure 3.2 H). By 4 dpf, crlf3 expression was observed in the thymus and the 
dorsal midline of midbrain (Figure 3.2 K), and from 7 dpf expression become stronger with 
additional expression observed in the exocrine pancreas and retina (Figure 3.2 M-P). Embryos 
treated with a JAK3 inhibitor (Changelian et al. 2003) that ablates T lymphocytes (Sertori et 
al. 2016) showed no crlf3 expression in the thymus (Figure 3.2 R), while those treated with 
DMSO only exhibited robust expression (Figure 3.2 Q).  
3.4 Generation and analysis of crlf3 knockout zebrafish 
 
The zebrafish Crlf3 protein (Figure 3.3A) is encoded by a gene that consists of nine exons and 
eight introns (Figure 3.3 B). To study the role of crlf3, TALEN (Figure 3.3 C) and CRISPR-
Cas9 (Figure 3.3 D) based genome editing approaches were designed to target specific sites in 
the coding region of exon 2. One-cell stage embryos were injected with in vitro transcribed 
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RNA either encoding a TALEN pair or encoding Cas9 plus a guide RNA and raised to 
adulthood. Potential F0 founders were crossed and their progeny analyzed by high-resolution 
melt analysis of PCR products spanning the target site followed by sequencing of potential 
mutants. To remove possible off-targeting, fish containing mutant alleles were outcrossed twice 
and homozygote F3 mutants were generated by in-crossing between heterozygote F2 mutants. 
Two, mutant alleles were identified representing a TALEN derived 1 bp deletion and a 
CRISPR-Cas9 derived 14 bp deletion (Figure 3.3 E). Both of these mutations truncated the 
Crlf3 protein by causing a frame-shift that introduced a premature stop codon (Figure 3.3 E).  
3.5 Phenotypic analysis of crlf3 mutant zebrafish 
 
3.5.1 Analysis of blood and immune cell development 
Given the strong expression of crlf3 at the sites of embryonic blood and immune cell 
development, and the extensive involvement of cytokine receptors in these lineages, this was 
explored extensively. 
3.5.1.1 Analysis of zebrafish primitive haematopoiesis 
The crlf3 mutants were first analysed for primitive hematopoiesis using WISH. At 14 hpf, crlf3 
mdu14/mdu14 mutants and their wild-type showed equivalent expression of scl, a marker of 
haemangioblasts (Dooley, Davidson & Zon 2005), both caudally and rostrally (Figure 3.4 A-
C and D-F), or of fli1, a marker of vascular precursors (Dooley, Davidson & Zon 2005), both 
caudally and rostrally (Figure 3.4 G-I and J-L). However, expression of ikzf1, a marker of 
haematopoietic precursors (Willett et al. 2001), was reduced caudally at 14 hpf (Figure 3.4 M-
O) by 34.4 ± 9.9%  and rostrally by 61.3 ± 8.7% (Figure 3.4 P-R), which was confirmed in 
crlf3mdu15/mdu15 that showed 41.2 ± 10.0%  and 70.3 ±10.2 % decreases, respectively (data not 
shown). A significant decrease was also observed in crlf3mdu14/mdu14 embryos for rostral spi1, a 
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marker of myeloid precursors (Bennett et al. 2001) (Figure 3.4 V-X). Moreover, the caudal 
expression of gata1, a marker erythroid precursors (Bertrand et al. 2007), was also reduced in 
crlf3mdu14/mdu14 embryos (Figure 3.4 Y-AA).  
Analysis of 22 hpf embryos confirmed equivalent expression of fli1 at this time point (Figure 
3.5 A-C). In contrast, significantly reduced expression persisted for ikzf1 (Figure 3.5 D-F) in 
crlf3mdu14/mdu14 compared to wild-type embryos. Additional analysis of lcp1 (Figure 3.5 G-I) 
and mpo (Figure 3.5 J-L), markers of monocytes (Berman, Kanki & Look 2005) and 
neutrophils (Lieschke et al. 2001), respectively, also revealed a decrease in crlf3mdu14/mdu14 
embryos. Finally, expression of hbbe (Figure 3.5, M-O), a marker of mature erythroid cells 
(Brownlie et al. 2003), was also decreased in crlf3mdu14/mdu14 mutants by 19.8 ± 9.0% that was 
confirmed in crlf3mdu15/mdu15 mutants by 18.8 ±8.8 % (data not shown). 
3.5.1.2 Analysis of zebrafish definitive haematopoiesis 
Next crlf3 mutants were examined with respect to definitive haematopoiesis, using a range of 
specific molecular markers. Significantly, crlf3mdu14/mdu14 embryos displayed decreased 
expression of c-myb, a marker of haematopoietic stem cells (HSC) (Emambokus et al. 2003) at 
3.5 dpf (Figure 3.6 A-C). However, at the same time point expression of ikzf1, a marker of 
lymphoid progenitors (Papathanasiou et al. 2003), was increased (Figure 3.6 D-F). At 5 dpf, a 
significant decrease was observed in mpl, a marker of thrombocyte precursors (Lin et al. 2017) 
in crlf3mdu14/mdu14 embryos (Figure 3.6 G-I). Expression of lcp1 was also reduced in 
crlf3mdu14/mdu14 embryos (Figure 3.6 J-L) by 28.3±6.5%, which was confirmed in crlf3mdu15/mdu15 
embryos with a 28.0±10.0% decrease (data not shown), at the same time point, as was 
expression of mpo (Figure 3.6 M-O). The crlf3mdu14/mdu14 embryos showed a decrease in 
expression of hbbe, a marker for mature erythrocytes (Jin et al. 2009) (Figure 3.6 P-R) and 
were slightly less stained with O-dianisidine (Figure 3.6 S-T) which is specific for  
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haemoglobulin (Chu et al. 2007). However, expression of rag1, a marker of mature lymphoid 
cells, (Willett, Cherry & Steiner 1997), was increased moderately in crlf3mdu14/mdu14 embryos 
by 32.0± 22.0% (Figure 3.6 U-W) and confirmed in crlf3 mdu15/mdu15 embryos by 17.7 ±15.5% 
(data not shown). Similar increases were also observed in the expression of tcrα in 
crlf3mdu14/mdu14 embryos (Figure 3.6 X-Z). Differential counts of blood from 5 dpf embryos 
confirmed a significant increase in the relative number of circulating lymphoid cells in mutants 
while the relative number of circulating erythrocytes, monocytes and neutrophils was 
decreased (Figure 3.6 AA-DD). In addition to this, there was a significant increase in blood 
clotting time in crlf3mdu14/mdu14 embryos compared to their wild-type counterparts (Figure 3.6, 
EE). 
3.5.1.3 Analysis of haematopoiesis in adult zebrafish 
The effects of crlf3 ablation on adult haematopoiesis were also assessed by histological analysis 
of blood, kidney, the zebrafish bone marrow equivalent (Rasighaemi et al. 2015), and spleen, 
which has similar immunological functions in zebrafish to human (Rasighaemi et al. 2015).  
Analysis of adult blood revealed that the number of circulating lymphocytes was increased in 
both crlf3mdu14/mdu14 and crlf3mdu15/mdu15 mutants compared to wild-types (Figure 3.7 A). A 
significant increase was also observed in the number of monocytes in crlf3mdu14/mdu14 and crlf3 
mdu15/mdu15 mutants. However, the number of neutrophils and thrombocytes was reduced in both 
crlf3mdu14/mdu14 and crlf3mdu15/mdu15 mutants compared to wild-type fish (Figure 3.7 A). Analysis 
of kidney marrow of crlf3mdu14/mdu14 and crlf3mdu15/mdu15 revealed reduced number of 
erythrocytes and neutrophils (Figure 3.7 B). In contrast, the number of lymphocytes, 
monocytes and eosinophils were increased in both crlf3mdu14/mdu14 and crlf3mdu15/mdu15 mutants 
compared to wild-types (Figure 3.7 B).  
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Analysis of spleen revealed no significant differences in individual cell populations in both 
crlf3mdu14/mdu14 and crlf3mdu15/mdu15 mutants compared to wild-type (Figure 3.7 C). In addition, 
no significant differences in the clotting time was observed between crlf3mdu14/mdu14 and wild-
type adult fish (Figure 3.7 D). 
3.5.2 Analysis of other aspects of development 
3.5.2.1 Analysis of other tissues where crlf3 is expressed 
Given the embryonic expression pattern of crlf3, the expression of markers specific for somites, 
eye, brain and exocrine pancreas were also examined. This revealed equivalent expression of 
myod, a marker of muscle lineages (Schnapp et al. 2009), at 14 hpf (Figure 3.8 A, B) and 22 
hpf (Figure 3.8 C, D), pax6, a marker for eye lens and brain which stain the retinal progenitor 
cells and ganglion cells (Wolf et al. 2009) at 5 dpf (Figure 3.8 E, F), and trypsin, a marker of 
the exocrine pancreas (Wendik, Maier & Meyer 2004) at 7 dpf (Figure 3.8 G, H) in 
crlf3mdu14/mdu14 mutant and wild-type embryos. 
3.5.2.2 Analysis of development and growth of crlf3 mutants 
Visual examination of crlf3 mutants revealed no obvious physical differences to their wild-
type siblings throughout embryogenesis (Figure 3.6, Figure 3.8 and data not shown), which 
continued in juveniles (Figure 3.9 A, B) and adults of either sex (Figure 3.9 D-G). This was 
reflected in no significant changes in length of crlf3mdu14/mdu14 compared to wild-type juveniles 
(Figure 3.9 C), and no significant changes in length, weight or BMI of crlf3mdu14/mdu14 adults of 
either sex compared to wild-type controls (Figure 3.9 H-M). 
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3.5.2.3 Analysis of survival and fecundity of crlf3 mutants 
To analyse survival, groups of wild-type and crlf3 mutant fish were followed from 1 dpf to 12 
weeks. Both crlf3mdu14/mdu14 and crlf3mdu15/mdu15 mutants showed equivalent survival to wild-type 
(Figure 3.10 A).  
The fecundity of crlf3wt/wt, crlf3 mdu14/mdu14 and crlf3mdu15/mdu15 fish was analyzed by mating 
success of three couples of fish examined three times and fertilization success analysed by 
fertilized eggs of fish. No significant differences were observed in mating success (Figure 3.10 
B) or fertilization success (Figure 3.10 C). 
3.6 Discussion 
 
Cytokines and cytokine receptors play a vital role in cell-to-cell communication important for  
haematopoiesis, immunity and other homeostatic processes (Liongue, Sertori & Ward 2016). 
A characteristic of cytokine receptors is the presence of a conserved cytokine receptor 
homology domain (CHD) in the extracellular domain of membrane bound receptors. In 
contrast,  cytokine receptor like factor 3 (Crlf3) consists of just a CHD (Liongue & Ward 2007). 
Homologues have been identified in many vertebrate species, but the  function of this protein 
has not been identified (Liongue & Ward 2007). 
This Chapter sought to explore the origin of Crlf3 through a bioinformatics analysis of key 
extant species as well as to examine its role using genome editing approaches in zebrafish. This 
suggested that Crlf3 might represents the archetypal CHD from which cytokine receptors were 
derived. In addition, it showed that zebrafish crlf3 mutants were overtly healthy and normal, 
with only minor haematopoietic phenotypes identified.  
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3.6.1 Crlf3 represents the archetypal cytokine receptor homology domain 
Classical cytokine receptors consist of at least one chain that possess an extracellular domain 
composed of a conserved cytokine receptor homology domain (CHD) with or without other 
modules, including extracellular immunoglobulin (Ig)-like and FBN domains, a 
transmembrane domain, and conserved intracellular sequences, including Box 1 and Box 2 
motifs that are associated with Janus kinase (JAK) docking (Liongue, Sertori & Ward 2016). 
Broadly, these cytokine receptors belong to two groups, Class I and Class II, based on the 
structural differences in the CHD (Liongue, Sertori & Ward 2016). The CHD of Class I 
receptor chains possess two pairs of cysteine that are linked by the disulphide bond in first 
fibronectin fold and  a highly conserved WSXWS motif in the second fibronectin fold but Class 
II cytokine receptor chains contain one pair of cysteine in each fibronectin fold without any 
WSXWS motif (Liongue, Sertori & Ward 2016). The CHD of cytokine receptor-like factor 3 
(Crlf3) has only one pair of cysteine but possesses a conserved WSXWS motif  and  displays 
greater similarity to the CHD of Class I cytokine receptors than Class II cytokine receptors 
(Liongue & Ward 2007). 
Sea squirt, the urochordate, possesses homologues for two protein containing Class I receptor-
type CHD: one related to Crlf3 and another to GP130, but none containing Class II type CHDs 
(Liongue & Ward 2007). Mammals and teleosts possess a single Crlf3 consisting of just a Class 
I-type CHD as well as an expanded Class I family and numerous Class II receptors. 
This suggested that the CHD was derived from either a Crlf3 ancestor or a GP130 ancestor. 
Fruit fly (Drosophila melanogaster) as a representative protostome, possessed a GP130 
homologue known as Dome but not Crlf3, which suggested GP130 was the archetypal cytokine 
receptor containing the archetypal CHD (Liongue & Ward 2007). However, in this Chapter, 
extensive bioinformatics analysis revealed evidence of Crlf3 in early metazoan genomes 
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including in the placozoan (Trichoplax adhaerens) with no evidence of Dome/GP130-like 
sequences. This suggests that Crlf3 in fact represents the archetype of at least of the CHD of 
this important protein family. However, despite the similarities to the cytokine receptor protein 
family, Crlf3 lacks features of a classical cytokine receptor. These include a leader sequence 
to mediate membrane trafficking protein or a transmembrane domain to secure it in a 
membrane. Only in bilateria these additional domains assembled to form a GP130-related 
sequence. This occurred coincidentally with generation of the JAK intracellular signalling 
kinase. Pre-existing STAT and SOCS proteins were then recruited into this pathway (Liongue 
& Ward 2007). The exact signaling mechanism and molecular functions of Crlf3 remain to be 
elucidated. 
3.6.2 Crlf3 expression shows broad conservation 
In this chapter, zebrafish crlf3 was found to be expressed in mesodermal derived tissues 
including haematopoietic tissues, such as the anterior lateral mesoderm (ALM), posterior 
lateral mesoderm (PLM) and posterior intermediate cell mass (pICM), and also sites populated 
by haematopoietic cells, including the adaxial cells, and pronephric duct, as well as, thymus 
and somites. This is consistant with on line data showing expression of Crlf3 in the adaxial cell 
and ventral mesoderm and in blood (Howe et al. 2012). In Xenopus embryos, expression of 
CRLF3 was observed in the mesodermal Keller explant (Karimi et al. 2017). Data from online 
resources also suggest that in mouse embryos Crlf3 expression occurs in the thymus (Smith et 
al. 2017).  
Additionally, crlf3 was expressed in some non-mesodermal tissues in zebrafish embryos, 
including the ectoderm-derived eye, and midline of midbrain, as well as endoderm-derived 
exocrine pancreas. In mouse embryos, Crlf3 was expressed in the ectoderm-derived mid brain, 
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and sensory organ, as well as endodermal genitourinary tract, ovary, testis, liver, biliary system 
and other visceral organs (Smith et al. 2017).  
In adult Xenopus, Crlf3 was expressed in the thymus (Karimi et al. 2017). Crlf3 expression was 
present in the thymus and spleen in adult mouse (Smith et al. 2017). Expression of CRLF3 was 
identified in the thymus, lymph nodes as well as at a higher level in the bone marrow in  human 
(Uhlén et al. 2015). However, in adult Xenopus, the expression of Crlf3 was also identified in 
the central nervous system, and testis (Karimi et al. 2017). In human, CRLF3 expression was 
observed in the central nervous system (Uhlén et al. 2015) while in adult mouse Crlf3 was 
expressed in the liver and limb (Smith et al. 2017). 
3.6.3 Crlf3 has haematopoietic functions 
Cytokine receptors play vital roles in blood and immune cells and crlf3 was expressed in 
haematopoietic tissues during zebrafish embryogenesis, suggesting that crlf3 may have a role 
in haematopoiesis at least during this development stage. Two genome editing technologies, 
TALEN and CRISPR-Cas9, were used to generate mutants of crlf3, crlf3mdu14/mdu14 and 
crlf3mdu15/mdu15, which were comprehensively analysed with respect to haematopoiesis. 
In early zebrafish embryogenesis, scl+ haemangioblasts (Dooley, Davidson & Zon 2005) give 
rise to ikzf1+ haematopoietic progenitor cells (Willett et al. 2001) as well as fli1+ vascular 
precursor cells (Dooley, Davidson & Zon 2005). During primitive haematopoiesis, the 
haematopoietic progenitor cells yield spi1+ myeloid precursors (Bennett et al. 2001) in the 
ALM and PLM, which mature into distinct lcp1+ monocytes (Berman, Kanki & Look 2005) 
that migrate rostrally and then laterally around the yolk sac and mpo+ neutrophils (Lieschke et 
al. 1994) as well as gata1+ erythroid precursors (Bertrand et al. 2007) in the PLM, which 
differentiate into hbbe+ primitive erythrocytes (Brownlie et al. 2003) that enter in the circulation 
and persist there for several days (Rasighaemi et al. 2015). The crlf3 mutants showed no 
                                                                               Chapter Three: Crlf3 evolution and function  
85 
alterations in the expression of scl and fli1 but the expression of ikzf1, gata1, and spi1 were 
reduced in crlf3mdu14/mdu14 and crlf3mdu15/mdu15 embryos.  
In the later stage of primitive haematopoiesis, lcp1, mpo and hbbe were decreased in crlf3 at 
22 hpf stage but no significant changes were observed in the expression of fli1. Collectively,  
these results indicate crlf3 plays a role in primitive haematopoiesis and loss of crlf3 decreases 
all primitive haematopoietic lineages, but does not affect vascular or haemangioblast cells, 
suggesting it may act at the level of the haematopoietic progenitor (Figure 3.11). 
During definitive haematopoiesis, cmyb+ haematopoietic stem cells are generated in the ventral 
wall of the dorsal aorta and migrate first to the caudal haematopoietic tissue (CHT) before final 
settlement in the kidney marrow while ikzf1+ lymphoid progenitors migrate to the thymus 
(Rasighaemi et al. 2015). The HSCs generate all the haematopoietic lineages. Definitive 
erythropoiesis starts in the CHT where gata1+ precursors yield hbbe+ mature erythrocytes. The 
definitive myelopoiesis begins at 3 dpf in the CHT where the spi1+ precursors differentiated 
into mature mpo+ neutrophils and lcp1+ monocytes. B cells are generated in the kidney from 
28 dpf. In the thymus rag1+ T lymphocytes are generated, which yield tcrα+ mature 
lymphocytes. The kidney and thymus continuously generate haematopoietic cells throughout 
adulthood. The crlf3 knockout embryos showed a significant decrease in c-myb+ definitive 
haematopoietic stem cells at 3.5 dpf along with reduction in erythropoiesis and myelopoiesis 
that resulted a decrease in hbbe+ mature erythrocytes, lcp1+ monocytes, mpo+ neutrophils and 
mpl+ thrombocytes at 5 dpf. In contrast, ikzf1+ lymphoid progenitors and rag1+ and tcrα+ T 
lymphocytes were significantly increased in crlf3 knockout embryos. This suggests a more 
complex role for crlf3 in definitive haematopoiesis, where it potentially exerts a positive effect 
on HSC and therefore downstream lineages, but a negative effect on lymphoid progenitors. 
Thus loss of crlf3 would then act by decreasing cmyb+ cells, leading to reduced myeloid and 
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erythroid cells, but increasing the lymphoid progenitors leading to increased rag1+ and tcrα+ T 
lymphocytes (Figure 3.12). 
Similar to mammals, zebrafish also possess a monocyte/macrophage lineage (Rasighaemi et 
al. 2015). This chapter showed the analysis of lcp1, previously described as 
monocyte/macrophage marker (Berman, Kanki & Look 2005). However, it has been 
subsequently shown to be a broader marker of leucocytes (Kell et al. 2018). It would, therefore, 
be essential to analyze a more widely-accepted macrophage marker, such as mpeg1.1 (Antonio 
et al. 2015), in Crlf3 zebrafish mutants to confirm that the monocyte/macrophage lineage is 
affected. 
Analysis of the blood of adult fish indicated an increase of lymphocytes and monocytes, but a 
decrease in neutrophils and thrombocytes, in crlf3 mutants compared to wild-type fish. In the 
kidney, there were also increased number of lymphocytes and monocytes (as well as 
eosinophils), while neutrophils (and erythrocytes) were decreased. Overall these changes are 
comparable to those observed in early definitive haematopoiesis, suggesting Crlf3 is exerting 
similar effect. However, no significant changes were observed in the spleens of crlf3 mutants. 
The kidney and thymus are the primary sites for haematopoiesis in adult zebrafish whereas 
spleen is a secondary site (Brownlie et al. 2003), making it likely that changes in the blood are 
more affected by changes in the kidney. 
3.6.4 Crlf3 has no other overt roles 
The crlf3 gene was also expressed in the developing somites, eye and exocrine pancreas during 
zebrafish embryogenesis. Based on this observation it was hypothesized that crlf3 might be 
involved in the development of muscle, eye or exocrine pancreas. However, no significant 
differences were observed in the expression of the muscle marker, myod, nor in swimming 
behaviour in crlf3 mutant compared to wild-type embryos (data not shown), suggesting no 
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overt issues in muscle development. Additionally, crlf3 mutant embryos showed a similar 
expression pattern to wild-types for the eye marker pax6, without any behavioral differences 
that might indicate impaired vision. Finally, expression of the exocrine pancreas marker, 
trypsin, was also similar in crlf3 mutant and wild-type embryos. Survival and reproduction 
were also not affected. This collectively suggests no major essential role for Crlf3. 
 
Although, Crlf3 showed strong expression at the site of embryonic blood and immune cell 
development, further analysis of crlf3 knockout zebrafish revealed minor haematopoietic 
phenotypes. In addition, the crlf3 gene was also expressed in the developing somites, eye and 
exocrine pancreas during zebrafish embryogenesis. However, Crlf3 ablation did not impact on 
the development of these tissues. Collectively, this confirms that strong expression does not 
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Figure 3.1: Characterization of Crlf3 orthologues. 
 
A-B. Phylogenetic analysis of full-length (A) and CHD (B) sequences from the indicated 
cytokine receptors using the Neighborhood-Joining algorithm, with bootstrap values above 
80% (of 1000 replicates) shown in bold.  
C. Alignment indicated Crlf3 sequences using Clustral X software. Conserved residues 
between these sequences are indicated as identical (*), highly similar (:) or similar (.), with 
hallmark CHD features shown (cysteine with pink arrows, WSXWS motif with red box). 
D. Synteny analysis of zebrafish crlf3 and human CRLF3 genes (blue arrows) along with 
syntenic SUZ12A gene orthologues (red arrows) and other adjacent genes (black arrows).  
Species used for analysis are indicated: placozoa, Trichoplax adherens (ta); cnidara, starlet sea 
anemone, Nematostella vectensis (nv); protostomia, fruit fly, Drosophila melanogaster (dm) 
and red flour beetle, Triboliun castaneum (tc); urochordata, sea squirt, Ciona intestinalis (ci); 
vertebrata, zebrafish, Danio rerio (dr) and human, Homo sapiens (hs). 
Panel A-B reproduced from Liongue, C, Taznin, T & Ward, AC (2016), and panel C modified 
from Liongue, C, Taznin, T & Ward, AC (2016), with permission from authors and Journal of 
Molecular Immunology.  
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Figure 3.2: Expression of the crlf3 gene during zebrafish embryogenesis. 
 
A-R. Spatio-temporal expression pattern of crlf3 during embryogenesis using WISH with sense 
(s) or antisense (as) crlf3 probes at the indicated time points on normal wild-type embryos 
(wt/wt) or those injected with 1 mM standard control (sc mo, H) or lycat (lycat mo, I) 
morpholino or bathed from 56 hpf in DMSO vehicle control (DMSO, Q) or JAK3 inhibitors 
(JAK3 inh, R). Embryos are dorsal view with anterior to the left (A, B, D, F, L, N, Q, R); 
ventral view with anterior to the left (C); lateral view with anterior to the left (E, J, K, M), 
except panel O that is ventral view with anterior to the left and P is front view (n = 20, repeated 
3 times).  
The indicated structures are: ALM (anterior lateral plate mesoderm), DMMB (dorsal midline 
of midbrain), EP (exocrine pancreas), pICM (posterior intermediate cell mass), PND 
(Pronephric duct), PLM (posterior lateral plate mesoderm), R (retina), SM (somites), TH 
(thymus). 
  









Figure 3.3: Targeting of zebrafish crlf3 using genome editing. 
 
A. Schematic representation of the zebrafish Crlf3 protein, consisting of a cytokine receptor 
homology domain (rounded rectangle) containing two conserved cysteines (C, thin lines) and 
a WSXWS motif (thick line). 
B-D. Schematic representation of the intron/exon structure of the zebrafish crlf3 gene, with 
exons represented as numbered boxes, showing untranslated (green) and translated (gray) 
regions, and introns represented with intervening lines (B). The nucleotide sequence of the 
target site on exon 2 and its targeting by the left and right TALENs (C) or CRISPR-Cas9 (D) 
are indicated with the PstI restriction site uderlined.  
E. Sequence traces of homozygous wild-type, crlf3wt/wt (wt/wt), and mutant crlf3mdu14/mdu14 
(mdu14/mdu14) and crlf3mdu15/mdu15 (mdu15/mdu15), with their respective translations below. 
The mdu14 and mdu15 alleles represent 1 bp and 14 bp deletions, respectively, the positions of 
which are shown with dotted purple and orange boxes, respectively, both of which cause a 
frameshift resulting in translation from an alternative reading frame followed by a stop codon 
that truncates the protein in each case. 
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Figure 3.4: Effect of crlf3 mutation on early primitive haematopoiesis. 
 
A-AA. Homozygous crlf3wt/wt (wt/wt), and crlf3mdu14/mdu14 (mdu14/mdu14) embryos at 14 hpf 
were subjected to WISH with scl (A, B, D, E), fli1 (G, H, J, K), ikzf1 (M, N, P, Q), spi1 (S, T, 
V, W) and gata1 (Y, Z). Individual embryos were assessed for area of scl (C, F), fli1 (I, L), 
ikzf1 (O, R), spi1 (U, X) and gata1 (AA), with the mean and SEM shown in red and level of 
statistical-significance indicated (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.05) (n = 20, 
repeated 3 times).  
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Figure 3.5: Effect of crlf3 mutation on later stage of primitive haematopoiesis. 
 
A-O. Homozygous crlf3wt/wt (wt/wt), and crlf3mdu14/mdu14 (mdu14/mdu14) embryos were 
subjected to WISH with fli1 (A, B), ikzf1 (D, E), lcp1 (G, H), mpo (J, K) and hbbe (M, N) at 
22 hpf. The area of staining was assessed for fli1 (C), ikzf1(F) and hbbe (O) and individual 
embryos were assessed for the number of lcp1+ (I) and mpo+ (L) cells, with the mean and SEM 
shown in red and level of statistical-significance indicated (**** p<0.0001, *** p<0.001, ** 
p<0. 01, * p<0.05) (n = 20, repeated 3 times). 
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Figure 3.6: Effect of crlf3 mutation on definitive haematopoiesis. 
 
A-Z. Homozygous wild-type crlf3wt/wt (wt/wt) and crlf3mdu14/mdu14 (mdu14/mdu14) embryos 
were subjected to WISH with c-myb (A, B) and ikzf1 (D, E) at 3.5 dpf, mpl (G, H), lcp1 (J, K), 
mpo (M, N), hbbe (P, Q), rag1 (U, V) and tcrα (X, Y) at 5 dpf or whole embryo staining with 
O-dianisidine (S, T) at 5 dpf. The area of staining was analysed for c-myb (C), ikzf1 (F), hbbe 
(R), rag1 (W) and tcrα (Z) cells and individual embryos were assessed for the number of mpl+ 
(I), lcp1+ (L) and mpo+ (O) cells with mean and SEM in red and statistical significance 
indicated (**** p<0.0001, *** p<0.001, ** p<0.01, * p<0.05). (n = 20, repeated 3 times). 
AA-DD. Blood smear of crlf3wt/wt (wt/wt), crlf3mdu14/mdu14 (mdu14/mdu14) and crlf3mdu15/md15 
(mdu15/mdu15) at 5 dpf stained with Giemsa (AA-CC), with quantitation of indicated cell 
populations (DD) with mean and SEM in red and statistical significance (**** p<0.0001, *** 
p<0.001, ** p<0.01, * p<0.05). (Abbreviations: e: erythrocyte, l: lymphocyte, n: neutrophil, p: 
precursor) (n = 20, repeated 3 times). 
EE. Clotting time for individual crlf3wt/wt (wt/wt) and crlf3mdu14/mdu14 (mdu14/mdu14) embryos, 
with mean and SEM shown in red and level of statistical-significance indicated (**** 
p<0.0001) (n = 20, repeated 3 times). 
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Figure 3.7: Effect of crlf3 mutation on adult haematopoiesis. 
 
A-C. Quantitation of individual cell populations from blood (A), kidney (B) and spleen (C) of 
crlf3wt/wt (wt/wt), crlf3mdu14/mdu14 (mdu14/mdu14) and crlf3mdu15/md15 (mdu15/mdu15) adult 
zebrafish with mean and SEM shown in red and statistical significance indicated (**** 
p<0.0001, *** p<0.001, ** p<0.01, * p<0.05) (n = 5, repeated 3 times).    
D. Clotting time for individual crlf3wt/wt (wt/wt) and crlf3mdu14/mdu14 (mdu14/mdu14) adult 
zebrafish with mean and SEM shown in red and statistical significance indicated (n =12, 
repeated = 3 times). 
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Figure 3.8: Effect of crlf3 mutation on other relevant embryonic tissues. 
 
A-H. Homozygous wild-type crlf3wt/wt (wt/wt), and crlf3mdu14/mdu14 (mdu14/mdu14) embryos 
were subjected to WISH with myod (A-D), pax6 (E, F) and trypsin (G, H), presented as caudal 
view (A, B), lateral view with anterior to left (C, D), anterior lateral view (E, F) and ventral 
view with anterior to the left (G, H) (n = 20, repeated = 3 times). 
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Figure 3.9: Effect of crlf3 mutation on growth. 
 
A-B, D-G. Representative images of 12 dpf juveniles (A, B) or adult male (D, E) and female 
(F, G) of crlf3wt/wt (wt/wt), and crlf3mdu14/mdu14 (mdu14/mdu14) fish. 
C, H-J, K-M.  Quantitation of 12 dpf juvenile length (C) and adult length (H, K), weight (I, L) 
and BMI (J, M) for male (H-J) and female (K-M) zebrafish with mean and SEM shown in red, 
and statistical significance indicated (ns = not significant) (n = 16, repeated =3 times). 
  









Figure 3.10: Effect of crlf3 mutation on survival and fecundity. 
 
A. Survival of crlf3wt/wt (wt/wt) (green line), crlf3mdu14/mdu14 (mdu14/mdu14) (olive line) and 
crlf3mdu15/md15 (mdu15/mdu15) (blue line), shown as a percentage in a Kaplan-Meier plot with 
statistical significance indicated (ns = not significant) (n = 20, repeated 3 times).  
B-C. Fecundity of crlf3wt/wt (wt/wt), crlf3mdu14/mdu14 (mdu14/mdu14) and crlf3mdu15/md15 
(mdu15/mdu15) assessed by mating success represented as percentage (%) and fertilization 
success as percentage (%) of fertilized eggs with mean and SEM shown in red and statistical 
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Figure 3.11:  Schematic representation of effect of crlf3 mutation on zebrafish primitive 
haematopoiesis. 
Primitive haematopoiesis of embryos carrying wild-type (A) and crlf3 mutant (B) with changes 
indicated with sheading and red arrows and potential site of crlf3 action in blue. (Abbreviation: 
Mono = Monocytes, Neutro = Neutrophils, Ery = Erythrocytes).
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                   Figure 3.12: Schematic representation of effect of crlf3 mutation on zebrafish 
definitive haematopoiesis.                           
Definitive haematopoiesis of embryos carrying wild-type (A) and crlf3 mutant (B) with 
changes indicated with sheading and red, green arrows as well as purple blunt arrow and 
potential site of crlf3 action in blue. (Abbreviation: Mono = Monocytes, Neutro = 



































Leptin is a well-characterized hormone in mammals that is secreted into the serum 
proportionately to adipose mass and signals via the leptin receptor (LEPR), also commonly 
known as the obese receptor (OBR) (Mattioli et al. 2005; Mercer et al. 1996b; Morton et al. 
2006; Zhao et al. 2003). Leptin and its cognate receptor have been demonstrated to have a role 
in food intake and glucose metabolism. Mutations in either leptin or leptin receptor genes 
caused hyperphagia and hypometabolism that result in obesity and type 2 diabetes, the latter of 
which included hyperglycaemia, hyperinsulinaemia, and insulin resistance (Denroche, Huynh 
& Kieffer 2012). 
The leptin receptor has also been implicated in immunity (Lam & Lu 2007). The long form of 
the leptin receptor, LEPRb, is expressed in human and mouse haematopoietic stem cells and 
human B cell progenitors (Bennett et al. 1996). Bone marrow (BM) cells  isolated from  leptin 
receptor deficient (db/db) mice had defective lymphoid colony-forming potentials (Lam & Lu 
2007). It has also been shown to impact on fertility (Hausman, Barb & Lents 2012). 
The basic structure of leptin and leptin receptor is largely conserved across vertebrates, 
suggesting leptin receptor may have conserved functions in fish and mammals. Indeed deletion 
of the leptin receptor in medaka fish caused a modest rise in food intake that affected the growth 
of juvenile, but not adult medaka (Chisada et al. 2014). 
This Chapter aimed to generate a zebrafish lepr knockout model to investigate the extent of 
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4.2 Generation of lepr knockout zebrafish 
 
To study the role of the lepr gene in zebrafish, a CRISPR-Cas9 based genome editing process 
was designed targeting a site in exon 7 of lepr, which was just after the sequence encoding the 
WSXWS motif of the first cytokine homology domain (CHD1) in the extracellular region 
(Figure 4.1 A-B). A pair of oligonucleotides was designed to generate a guide RNA (gRNA) 
targeting a specific sequence in this exon (Figure 4.1 C). At the one-cell stage, embryos were 
injected with in vitro transcribed gRNA and mRNA encoding Cas9 and raised to adulthood. 
High-resolution melt analysis was used to screen for potential founder (F0) fish, followed by 
sequencing. Two mutant alleles were identified, mdu18, harbouring a combined 1 bp deletion 
and 14 bp insertion, and mdu19, harbouring a combined 2 bp deletion and 20 bp insertion 
(Figure 4.1 D). Both lepr mutations introduced an in-frame stop codon that would severely 
truncate the encoded protein (Figure 4.1 D).  
4.3 Effect of lepr mutation on development, fecundity, and survival of 
zebrafish 
 
In mammals, LEPR is involved in food intake and metabolism that impacts on the development 
and growth (Yang & Barouch 2007). The generation of lepr mutant alleles allowed the 
assessment of the role of lepr throughout the zebrafish lifespan.  
4.3.1 Analysis of the development, growth and survival of lepr mutants 
The leprwt/wt and leprmdu18/mdu18 fish were monitored for development, growth and survival from 
the embryonic stage to adulthood. No significant differences were observed in the development 
of leprwt/wt and leprmdu18/mdu18 during embryogenesis (data not shown), as juveniles (Figure 4.2 
A-B) or adults (Figure 4.2 C-F). The leprmdu18/mdu18 and leprmdu19/mdu19 mutants also had similar 
survival rates compared to wild-types (Figure 4.2 G). 
                                                                                    Chapter Four: Lepr function in zebrafish  
115 
4.3.2 Analysis of fecundity of lepr mutants  
The effect of lepr mutation on the fecundity of fish was analyzed by investigating the mating 
and fertilization success of leprwt/wt, leprmdu18/mdu18 and leprmdu19/mdu19 fish. Fish of each 
genotype showed equivalent mating success (Figure 4.2 H) and fertilization success (Figure 
4.2 I).  
4.4 Effect of lepr mutation on metabolism 
 
4.4.1 Analysis of basal metabolic parameters of lepr mutant 
Leptin and leptin receptor deficiency in mammal causes alternations in metabolism, resulting 
in elevated BMI and changes in many tissues such as liver and fat (Houseknecht & Portocarrero 
1998). The length of wild-type leprwt/wt and leprmdu18/mdu18 juveniles were measured at 12 dpf 
with no differences observed (Figure 4.3 A). Adult male and female leprwt/wt and leprmdu18/mdu18 
fish at 6 months of age were also measured for length and weight and BMI was calculated. No 
differences in the length (Figure 4.3 B, E), weight (Figure 4.3 C, F) or BMI (Figure 4.3 D, G) 
were seen between leprwt/wt and leprmdu18/mdu18 fish. 
Liver and white fat were also collected from male leprwt/wt and leprmdu18/mdu18 fish. No gross 
differences were observed in either gross morphology of liver (Figure 4.4 A, B) or white fat 
(Figure 4.4 C, D) or weight of liver (Figure 4.4 E) or white fat (Figure 4.4 F) between leprwt/wt 
and leprmdu18/mdu18 fish. The basal glucose level was also analyzed after overnight fasting, with 
no significant differences observed in fasting glucose between the leprwt/wt and leprmdu18/mdu18 
fish (Figure 4.4 G). 
4.4.2 Analysis of metabolic parameters following over-feeding of lepr mutant 
Over-feeding has been shown to increase BMI in many fish which ultimately effects organs 
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related to metabolism (Oka et al. 2010). To investigate the role of lepr in response to altered 
calorific intake, groups of 3 month old male leprwt/wt and leprmdu18/mdu18 fish were subjected to 
either over-feeding (60 mg Artemia/fish/day) or restricted feeding (5 mg Artemia/fish/day). 
After 12 weeks, fish were imaged, measured for length and weight and BMI was calculated 
with liver and white fat also imaged and weighed. Over-feeding significantly increased the 
overall size of fish (Figure 4.5 B, D), liver (Figure 4.5 G, K), and white fat (Figure 4.5 H, L) 
as well as length (Figure 4.6 A), weight (Figure 4.6 B), BMI (Figure 4.6 C), liver weight (Figure 
4.6 D) and white fat weight (Figure 4.6 E) in both genotypes. However, no significant 
differences were observed in any of these parameters between leprwt/wt and leprmdu18/mdu18 under 
either feeding condition, except for the BMI of leprmdu18/mdu18 that increased significantly 
compared to leprwt/wt following over-feeding (Figure 4.6 C). In addition, over-feeding caused a 
significant increase in fasting glucose of leprmdu18/mdu18 that was not observed in leprwt/wt fish, 
despite no significance differences between leprwt/wt and leprmdu18/mdu18 under restricted feeding 
conditions (Figure 4.6 F).  
4.5 Effect of lepr mutation on haematopoiesis  
 
Leptin and leptin receptor have been proposed to play a role in mammalian haematopoiesis 
(Mattioli et al. 2005). Therefore, haematopoiesis was investigated in lepr mutants. 
4.5.1 Analysis of embryonic haematopoiesis of lepr mutants 
To investigate the potential role of lepr in definitive haematopoiesis, WISH was employed 
using a range of specific molecular markers on 5 dpf leprwt/wt and leprmdu18/mdu18 embryos. No 
significant differences was observed in the number of lcp1+ (monocyte) (Figure 4.7 A-C) or 
mpo+ (neutrophil) (Figure 4.7 D-F) cells or in the area of expression for hbbe (erythrocyte) 
(Figure 4.6 G-I) and rag1 (T lymphocyte) (Figure 4.7 J-L). 
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4.5.2 Analysis of haematopoiesis in adult lepr mutants 
Histological analysis of adult blood revealed no significant differences in the relative number 
of circulating lymphocytes, neutrophils, monocytes, thrombocytes and precursors between 
leprwt/wt and either leprmdu18/mdu18 or in leprmdu19/mdu19 fish (Figure 4.8 A). Similar analysis of 
adult kidney marrow revealed that the number of erythrocyte was increased in leprmdu18/mdu18 
and leprmdu19/mdu19 compared to leprwt/wt (Figure 4.8 B) while the number of neutrophils was 
decreased (Figure 4.8 B). Analysis of spleen showed an increased number of lymphocytes and 
neutrophils in leprmdu18/mdu18 and leprmdu19/mdu19 compared to leprwt/wt (Figure 4.8 C).  
4.6 Discussion 
 
In mammals including mice, human and rodents, leptin (LEP) and leptin receptor (LEPR) are 
principally involved in regulation of food intake and metabolism (Ahima & Osei 2004). 
Mutation of Lepr is associated with increased appetite that results in morbid obesity and 
diabetes in mice (Genuth, Przybylski & Rosenberg 1971; Grundleger, Godbole & Thenen 
1980; Yang & Barouch 2007). Fish also possess leptin and leptin receptor (Ronnestad et al. 
2010). In zebrafish, expression of leptin receptor (lepr) was demonstrated to first appear in the 
notochord during embryogenesis and in trunk muscles and gut (Liu et al. 2010). In both larval 
and adult zebrafish, lepr was expressed in the hindbrain as well as other brain regions, such as 
the hypothalamic lateral tuberal nucleus, and also several adult tissues, including muscle, liver, 
and gonads (Liu et al. 2010). 
This Chapter aimed to investigate the function of zebrafish lepr by the generation of mutant 
alleles using CRISPR-Cas9 genome editing and analysis of fish harbouring these alleles with 
respect to development, metabolism, reproduction and haematopoiesis. 
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4.6.1 Lepr in zebrafish development, growth, fecundity and survival 
LEPR has role in appetite control and metabolism, with loss of function of leptin or LEPR 
resulting in increased food intake that ultimately causes obesity (Houseknecht & Portocarrero 
1998; Mattioli et al. 2005). The nutritional status is significantly regulated by the balance 
between leptin and other hormones that has influence on many organ systems, such as, liver, 
brain, and skeletal muscle. The metabolic signal of leptin regulates the growth hormone (GH) 
secretion that suppressed by obesity and underweight (Carro et al. 1997). Leptin play a vital 
role that starts from neonatal life and continues to adolescence, where it regulates growth, bone 
development, and puberty (Kelesidis & Mantzoros 2006). Growth analysis of leprmdu18/mdu18 
revealed that zebrafish carrying an inactivating mutation of lepr displayed no significant 
changes in growth at the juvenile stage. This feature continued to adulthood, with no significant 
changes observed in length and weight. 
Leptin increases the secretion of gonadotropin hormones, which are essential for initiation and 
maintenance of reproductive function (Hausman, Barb & Lents 2012). Leptin also regulates 
the ovary by regulating follicular and luteal steroidogenesis (Hausman, Barb & Lents 2012). 
This Chapter revealed no differences in fecundity between either leprmdu18/mdu18 or 
leprmdu19/mdu19 compared to wild-type fish. Similarly, leprsa1508/sa1508 mutants showed no 
differences in mating or fertilization success compared to wild-types (Michel et al. 2016). 
4.6.2 Lepr in zebrafish metabolism 
Adult leprmdu18/mdu18 and leprmdu19/mdu19 fish showed no overt sign of obesity and no differences 
in body mass index (BMI), liver or fat at 6 months. Similarly the leprsa1508/sa1508 mutants showed 
no differences in BMI (calculated from length and weight) compared to wild-type fish at  4 or 
5.5 months (Michel et al. 2016). Analysis of lepr-/- medaka demonstrated increased food intake 
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and a transient increase in body weight of 1.6 to 2 fold in the post-juvenile stage but adults 
were not significantly different (Chisada et al. 2014).  
Overfeeding of zebrafish with artemia has been shown to lead to increased BMI compared to 
restricted feeding (Oka et al. 2010; Ronnestad et al. 2010).  Both leprwt/wt and leprmdu18/mdu18 
fish showed an increase in BMI following over-feeding compared to restricted feeding, but the 
BMI of leprmdu18/mdu18 was increased significantly compared to wild-type fish following over-
feeding. Increased weight following over-feeding was also observed with leprsa1508/sa1508 
mutants but there was no data for the analysis of length and BMI (Michel et al. 2016).  
In contrast, neither the liver weight nor fat weight of leprmdu18/mdu18 fish was significantly 
increased compared to wild-type fish following overfeeding. Adult leprmdu18/mdu18 exhibited 
euglycemia (normal level of glucose in blood), similar to  leprsa1508/sa1508 fish (Michel et al. 
2016). However, the glucose level of leprmdu18/mdu18 was increased compared to wild-type fish 
following overfeeding. These suggest that the leprmdu18/mdu18 was less physically active 
compared to leprwt/wt during overfeeding which increased the fasting glucose. There was no 
data for fasting glucose for leprsa1508/sa1508 fish under over-feeding conditions (Michel et al. 
2016). 
4.6.3 Lepr in zebrafish haematopoiesis 
Leptin has been proposed to play a regulatory role in haematopoiesis. Leptin has been shown 
to enhance proliferation and apoptotic activities in diverse cell types, for example, T 
lymphocytes, and haematopoietic progenitors (Polakof et al. 2012). However, in this study, no 
significant changes were observed in haematopoiesis in leprmdu18/mdu18 compared to wild-type 
embryos. This is consistent with previous studies that suggested lepr was not expressed in 
haematopoietic tissues during zebrafish embryogenesis (Liu et al. 2010). Analysis of adult 
leprmdu18/mdu18 fish revealed a significant increase in erythrocytes but decrease in neutrophils in 
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kidney marrow  and a significant increase in lymphocytes and neutrophils in the spleen 
compared to wild-type fish. Over all this result was surprising since no evidence of lepr 
expression was previously observed in adult zebrafish haematopoietic tissues such as kidney, 
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Figure 4.1: Targeting of lepr in zebrafish with CRISPR-Cas9. 
 
A. Schematic representation of the Lepr, consisting of two cytokine receptor homology 
domains (CHD) with conserved cysteine (thin lines) and WSXWS motif (thick line) along with 
two immunoglobulin (Ig) and fibronectin type III (FBNIII) domains in the extracellular region, 
and Box 1, Box 2 and Box 3  in the intracellular region.  
B-C. Schematic representation of part of the zebrafish lepr gene (B). The exons are represented 
as numbered boxes (green), with the introns represented by a thin line. Expanded nucleotide 
sequence of part of exon (C) showing the CRISPR-Cas9 target site (italic). 
D. Sequence of homozygous leprwt/wt (wt/wt), leprmdu18/mdu18 (mdu18/mdu18) and leprmdu19/mdu19 
(mdu19/mdu19) fish with respective translations shown below. The mdu18 allele represents a 
combined 1 bp deletion (orange dotted) and 14 bp insertion (orange solid box) while the mdu19 
allele represents a combined 2 bp deletion (purple dotted box) and 20 bp insertion (purple solid 
















Figure 4.2: Effect of lepr mutation on development, growth, survival and fecundity. 
 
A-F. Representative images of the overall development and growth of leprwt/wt (wt/wt) and 
leprmdu18/mdu18 (mdu18/mdu18) juveniles (A, B), as well as adult male (C, D) and female (E, F) 
fish. 
G. Relative survival of leprwt/wt (wt/wt) (yellow line), leprmdu18/mdu18 (mdu18/mdu18) (green 
line) and leprmdu19/mdu19 (blue line) fish displayed as a Kaplan-Meier plot with statistical 
significance indicated (ns = not significant). 
H-I. Fecundity of leprwt/wt (wt/wt), leprmdu18/mdu18 (mdu18/mdu18) and leprmdu19/mdu19 
(mdu19/mdu19) assessed by mating success represented as percentage (%) and fertilization 
success as percentage (%) of fertilized eggs with mean and SEM shown in red and statistical 
significance indicated (ns = not significant). (n = 3 [panel H] or 8 [panel I], repeated 3 times). 
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Figure 4.3: Effect of lepr mutation on size and BMI. 
 
A. Quantitation of length of individual juvenile leprwt/wt (wt/wt) and leprmdu18/mdu18 
(mdu18/mdu18) fish with mean and SEM in red and statistical significance indicated (ns =not 
significant). 
B-G. Assessment of individual adult male (B-D) and female (E-G) of leprwt/wt (wt/wt) and 
leprmdu18/mdu18 (mdu18/mdu18) fish for length (B, E), weight (C, F) and calculated BMI (D, G) 
with mean and SEM shown in red and level of significance indicated (ns = not significant). (n 
= 20, repeated = 3 times).  
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Figure 4.4: Effect of lepr mutation on liver, fat and fasting glucose level. 
 
A-D. Representative images of liver (A, B) and white fat (C, D) of male adult leprwt/wt (wt/wt) 
(A, C) and leprmdu18/mdu18 (mdu18/mdu18) (B, D) fish. 
E-G. Assessment of individual fish for weight of liver (E), white fat (F) and fasting blood 
glucose level (G). Mean and SEM are shown in red and level of statistical significance indicated 
(ns = not significant). (n = 7, repeated = 2 times). 
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Figure 4.5: Effect of lepr mutation on response of adult fish to over-feeding. 
 
A-D. Representative images of male leprwt/wt (wt/wt) (A, B) and leprmdu18/mdu18 (mdu18/mdu18) 
fish (C, D) following restricted feeding (RF: A, C) and over-feeding (OF: B, D) for three 
months.  
E-L. Representative images of liver (E, G, I, & K) and white fat (F, H, J, & L) from leprwt/wt 
(wt/wt) and leprmdu18/mdu18 (mdu18/mdu18) fish following restricted feeding (RF) and over 
feeding (OF) (n = 7, repeated = 2 times).   
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Figure 4.6: Effect of lepr mutation on metabolic parameters following over-feeding. 
 
A-F. Assessment of length (A), body weight (B), calculated BMI (C), liver (D), white fat (E) 
and fasting blood glucose level (F) of male leprwt/wt (wt/wt) and leprmdu18/mdu18 (mdu18/mdu18) 
fish following restricted feeding (RF) and over-feeding (OF) for three months. The mean and 
SEM are shown in red and level of statistical significance indicated (****p<0.0001, 
***p<0.001, **p<0.01, *p<0.05, ns = not significant). (n = 7, repeated = 2 times).  
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Figure 4.7: Effect of lepr mutation on definitive haematopoiesis. 
 
A-L. Homozygous leprwt/wt (wt/wt) and leprmdu18/mdu18 (mdu18/mdu18) embryos were subjected 
to whole mount in situ hybridization (WISH) with lcp1 (A, B), mpo (D, E), hbbe (G, H) and 
rag1 (J, K) at 5 dpf. The number of lcp1+ (C) and mpo+ (F) cells and the area of expression 
(exp.) of hbbe (I) and rag1 (L) was quantified with mean and SEM shown in red and statistical 
significance indicated (ns = not significant). (n = 20, repeated = 3 times).  
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Figure 4.8: Effect of lepr mutation on adult haematopoiesis. 
 
A-C. Differential count of individual cell populations of blood (A), kidney (B) and spleen (C) 
from homozygous leprwt/wt (wt/wt), leprmdu18/mdu18 (mdu18/mdu18) and leprmdu19/mdu19 
(mdu19/mdu19) adult fish with  mean and SEM shown in red and statistical significance 
indicated ( **** p<0.0001, *** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (n =5; 
repeated = 3 times).   

































Prolactin (PRL), a hormone synthesized and secreted by cells of the pituitary gland, acts via 
the prolactin receptor (PRLR) (Brisken et al. 1999). A significant role for the PRL/PRLR 
signaling axis in mammals is its contribution in mammary gland development and lactation 
(Bole-Feysot et al. 1998; Freeman et al. 2000) which is principally mediated via JAK2-
STAT5A (Radhakrishnan et al. 2012).  More generally in other vertebrates, PRL can stimulate 
lactogenesis, maternal behavior, growth, development, osmoregulation and ion transport (Shu 
et al. 2016). Moreover, PRLR is present in different tissues suggesting its involvement in many 
functions (Foitzik, Langan & Paus 2009; Huang, Snider & Cross 2008; Rivera et al. 2008; 
Sackmann-Sala, Guidotti & Goffin 2015). Additionally, PRL has a proposed role in T 
lymphocyte proliferation via the activation of mitogenic factors or antigen presentation (Matera 
et al. 1992; Murphy, Durum & Longo 1993).  
Despite its pleiotropic functions, PRLR is more generally studied for its mammalian-specific 
functions, mammary gland development and lactation (Bole-Feysot et al. 1998). Teleosts lack 
analogs for these mammalian features, thus presenting an opportunity to investigate other 
functions of this pleiotropic signaling axis. Prl knockdown zebrafish larvae lacked a swim 
bladder, with a reduced body length, reduced head, fewer proliferating cells, eye size, and brain 
ventricle (Zhu et al. 2007). Moreover, prl-/- zebrafish embryo raised in freshwater (FW, salinity 
60-175 mg/L) showed increased mortality at 6 dpf with none surviving past 20 dpf (Shu et al. 
2016). However, they were able to survive in brackish water (BW, salinity 5060-5175 mg/L). 
In FW, prl-/- also showed a failure in swim bladder inflation along with hydrocardia, edema 
and a curved body. Additionally, prl-/- juveniles had a defect in jaw and bone formation in 
hypotonic water with low concentration of Ca2+ (HWLC) which was rescued by hypotonic 
water with high concentration of Ca2+ (HWHC) (Shu et al. 2016). Like many teleosts, zebrafish 
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have two paralogues of prlr.a that are prlr.a and prlr.b (Huang et al. 2007). prlr.a was 
expressed in the pro-nephric duct, and pancreas at 24 hpf whereas in adult fish it was expressed 
in many organs such as olfactory organs, brain, eyes, intestines, ovaries, and spleen. Expression 
of prlr.b was evident in gills, kidney, testes, ovaries, intestines, livers, scales, brain, lipid, eyes 
and spleen (Kelly et al. 1991). In zebrafish, there are two Prlr paralogues, Prlr.a and Prlr.b, that 
are capable of transducing Prl signals (Whittington & Wilson 2013). Zebrafish also have two 
paralogues for Jak2, Jak2a and Jak2b and Stat5, Stat5.1 and Stat5.2 (Liongue et al. 2012).  
This Chapter aimed to generate prlr.a knock out zebrafish to investigate the role of prlr.a. This 
involved analyzing the development, growth, survival and fecundity of prlr.a mutants and 
especially their swim bladder, bone, blood and immune cells. 
5.2 Generation of prlr.a knock out zebrafish 
 
To understand the role of prlr.a, a TALEN-based genome editing approach was adopted to 
target a site exon 4 (Figure 5.1 B). In vitro transcribed RNA encoding each TALEN was 
injected into embryos at the one-cell stage and raised to adulthood. Conveniently, the sequence 
between the TALEN target sites contained a BamHI restriction enzyme cut site that was used 
to screen for successful genome editing events (Figure 5.1 C). Potential F0 founder was crossed 
and analysed by BamHI restriction enzyme digestion. Those missing a BamHI site were 
subjected to sequencing. This process successfully identified two alleles, mdu16, harbouring a 
combined 4 bp deletion and 2 bp insertion, and mdu17, harbouring a combined 3 bp deletion 
and 4 bp insertion (Figure 5.1 D). Both of these represent frameshift mutations that serve to 
introduce a premature stop codon, thereby truncating of the encoded Prlr.a protein (Figure 5.1 
D). To remove potential off-targeting, fish containing mutant alleles were outcrossed twice. 
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5.3 Effect of prlr.a mutation on development, growth, survival, and 
fecundity 
 
Prl plays a vital role in the development and growth of vertebrates (Kelly et al. 1991). In 
mammals, PRLR also plays a role in reproduction (Gorvin 2015). These were investigated in 
zebrafish prlr.a mutants. 
5.3.1 Analysis of the development and growth of prlr.a mutant 
Both prlr.awt/wt and prlr.amdu16/mdu16 fish were monitored for the development, growth and 
survival from the embryonic stage to adulthood. However, no significant differences were 
observed in the development of prlr.awt/wt and prlr.amdu16/mdu16 during embryogenesis (data not 
shown), or at juvenile (Figure 5.2 A-B) or adult (Figure 5.2 C-F) stages.  
The jaw to head length and the total length of prlr.awt/wt and prlr.amdu16/mdu16 juveniles were 
measured at 12 dpf, and no significant differences were observed (Figure 5.3 A, B). At 4 
months, adult male and female of prlr.awt/wt and prlr.amdu16/mdu16 fish were measured for length 
and weight. No significant differences in length (Figure 5.3 C, F), weight (Figure 5.3 D, G), or 
calculated BMI (Figure 5.3 E, H) were seen between prlr.awt/wt and prlr.amdu16/mdu16 fish of 
either sex. 
5.3.2 Analysis of survival and fecundity of adult prlr.a mutants 
 Monitoring during the first 12 weeks revealed that prlr.awt/wt, prlr.amdu16/mdu16, and 
prlr.amdu17/mdu17 fish possessed similar survival rates (Figure 5.4 A). Adult prlr.awt/wt, 
prlr.amdu16/mdu16 and prlr.amdu17/mdu17 fish also had equivalent mating success (Figure 5.4 B) and 
fertilization success (Figure 5.4 C).  
5.4 Effect of prlr.a mutation on Prl mediating functions 
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Prl deficient (prl-/-) zebrafish died very quickly in fresh water (Shu et al. 2016). The prl-/- 
zebrafish larva also had a defect in bone formation when raised in hypotonic water with a low 
concentration of calcium which was rescued effectively in high concentrations of calcium. 
Additionally, the prl-/- zebrafish embryos had a defective swim bladder that caused a curved 
body (Shu et al. 2016). This study aimed to investigate the role of Prlr.a/Stat5 signaling in 
mediating the functions of Prl. Therefore, in addition to prlr.a mutants, three previously 
generated mutants were used in this study. mdu22, a mutant allele of stat5.1, harbouring a 47 
bp insertion, mdu23, a mutant allele of stat5.2, harbouring a 77 bp insertion and a double mutant 
allele, mdu22+mdu23, representing a cross of the mdu22 and mdu23 alleles and so mutant for 
both stat5.1 and stat5.2. 
5.4.1 Analysis of survival of prlr.a mutant embryos 
The prlr.awt/wt, prlr.amdu16/mdu16, prlr.amdu17/mdu17, stat5.1mdu22/mdu22 and stat5.2mdu23/mdu23  
embryos raised in fresh water (FW) (salinity: 60-175 mg IOS/L) showed similar survival rates 
(Figure 5.5). However, a slightly reduced survival rate was observed in stat5mdu22/22+mdu23/23 
embryos (Figure 5.5). 
5.4.2 Analysis of swim bladder inflation in prlr.a mutants 
To investigate the role of prlr.a in swim bladder inflation prlr.awt/wt, prlr.amdu16/mdu16, 
prlr.amdu17/mdu17, stat5.1mdu22/mdu22, stat5.2mdu23/mdu23 and stat5mdu22/22+mdu23/23 mutants were 
morphologically examined 9 dpf after being raised in FW (Figure 5.6 A-L). The prlr.awt/wt 
(Figure 5.6 A, B), prlr.amdu16/mdu16 (Figure 5.6 C, D), prlr.amdu17/mdu17 (Figure 5.6 E, F) and 
stat5.1mdu22/mdu22 (Figure 5.6 G, H) juveniles showed similar robust swim bladder inflation. 
However, 9.3% of stat5.2mdu23/mdu23 (Figure 5.6 I, J) and 32% of stat5mdu22/22+mdu23/23 (Figure 5.6 
K, L) juveniles failed to inflate their swim bladder (Figure 5.6 M).  
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5.4.3 Analysis of jaw and bone formation in prlr.a mutants 
Bone formation in prlr.awt/wt, prlr.amdu16/mdu16, prlr.amdu17/mdu17, stat5.1mdu22/mdu22 and stat 
5.2mdu23/mdu23 juveniles raised in FW, HWLC and HWHC was analysed at 11 dpf. A significant 
reduction in jaw bone formation was observed for prlr.amdu16/mdu16 (Figure 5.7 D), 
prlr.amdu17/mdu17 (Figure 5.7 G), stat5.1mdu22/mdu22 (Figure 5.7 J) and stat5.2mdu23/mdu23 (Figure 5.7 
M) compared to prlr.awt/wt juveniles (Figure 5.7 A) in FW although this was less for 
stat5.1mdu22/mdu22 and stat5.2mdu23/mdu23. Similar results were seen for juveniles raised in HWLC 
(Figure 5.7 E, H, K) but to a reduced extent, and stat5.2mdu23/mdu23 juveniles (Figure 5.7 N) no 
longer showed any significant differences compared to prlr.awt/wt. HWHC (Figure 5.7 F, I, L) 
largely rescued the effects, although prlr.amdu16/mdu16 and prlr.amdu17/mdu17 remained significantly 
less than prlr.awt/wt (Figure 5.7 U).  
A significant reduction was also observed in bone formation in prlr.amdu16/mdu16 (Figure 5.8 D), 
prlr.amdu17/mdu17 (Figure 5.8 G) and stat5.1mdu22/mdu22 (Figure 5.8 J) juveniles in FW compared 
to prlr.awt/wt (Figure 5.8 A). Similar results were also observed in HWLC (Figure 5.8 E, H, K) 
to a less extent. However, HWHC rescued the effects effectively (Figure 5.8 F, I, L). The bone 
formation in prlr.amdu16/mdu16, prlr.amdu17/mdu17 and stat5.1mdu22/mdu22 remained significantly less 
than to prlr.awt/wt in HWHC (Figure 5.8 X). However, no significant reduction was observed in 
stat5.2mdu23/mdu23 juveniles in FW (Figure 5.8 M), HWLC (Figure 5.8 N) and HWHC (Figure 
5.8 O). 
5.5 Effect of prlr.a mutation on haematopoiesis 
 
In mammals, PRL has a proposed role in haematopoiesis (Murphy, Durum & Longo 1993). 
So, the potential involvement of prlr.a of haematopoiesis was also investigated. 
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5.5.1 Analysis of definitive haematopoiesis in prlr.a mutants 
Definitive haematopoiesis was investigated by WISH using a range of specific molecular 
markers on prlr.awt/wt and prlr.amdu16/mdu16 embryos at 5 dpf. No significant differences were 
observed in the number of lcp1+ (monocyte) (Figure 5.9 A-C) or mpo+ (neutrophil) (Figure 5.9 
D-F) cells. Similarly, there were no significant differences in the area of expression for hbbe 
(erythrocyte) (Figure 5.9 G-I) and rag1 (T lymphocyte) (Figure 5.9 J-L) staining. 
5.5.2 Analysis of adult haematopoiesis of prlr.a mutants 
Adult haematopoiesis was examined by histological analysis of key tissues. Differential 
counting of blood (Figure 5.10 A), kidney (Figure 5.10 B) and spleen (Figure 5.10 C) revealed 
no significant differences in  erythrocytes, lymphocytes, neutrophils, monocytes, thrombocytes 




The diverse biological functions of prolactin /growth hormone superfamily are well known in 
adult vertebrates (Ormandy et al. 1997). However, there is less information available on the 
roles of Prl and related hormones before the adult stage of development (Kelly et al. 1991). 
This Chapter aimed to understand the role of prlr.a by assessing prlr.a mutant zebrafish 
through the life-span. 
5.6.1 Prlr.a mediates a subset of the functions of Prl in zebrafish 
5.6.1.1 Prlr.a is not essential for embryo survival  
In mammals, PRL is involved in foetal osmoregulation in early gestation while it acts as a 
water-adapting hormone in fish, which plays a crucial role in the protection of ion loss to the 
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external hypo-osmotic environment essential for survival and homeostasis (Nguyen, Stellwag 
& Zhu 2008). The results in this Chapter showed that prlr.a, stat5.1, and stat5.2 mutant 
embryos survived well in FW. Previous studies revealed that prl-/- juveniles could not survive 
in FW and started to die after 6 dpf (Shu et al. 2016). This result suggested that Prlr.a signalling 
is not directly involved in Prl-mediated zebrafish survival. 
5.6.1.2 Prlr.a is not essential for swim bladder inflation  
Defects in swim bladder inflation mediate low survival of fish due to spinal deformities which 
impact on feeding ability (Woolley, Fielder & Qin 2014). This Chapter did not reveal any 
changes in the inflation of swim bladder in either prlr.a or stat5.1 mutants compared to wild-
type, but stat5.2 and combined stat5.1/stat5.2 fish exhibited defective swim bladder inflation, 
as observed in  prl-/-  juvenile zebrafish (Shu et al. 2016). This suggests that Prlr.a also plays 
no role in the signalling of Prl mediating swim bladder inflation, although Stat5.2 potentially 
does, with Stat5.1 playing a lesser role. 
5.6.1.3 Prlr.a plays a role in jaw and bone formation 
The prl-/- deficient fish that showed defective bone formation (Shu et al. 2016) that could be 
rescued by high concentrations of Ca2+ solution, suggesting impaired Ca2+ homeostasis as the 
cause (Shu et al. 2016). This prlr.a mutants had a defect in bone formation in FW which could 
also be rescued by high calcium. Similar, albeit lesser effects, were observed in stat5.1 mutants 
suggesting Stat5.1 also plays a role in bone formation along with a minor effect in stat5.2 
mutants.  
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5.6.2 Prlr.a has no other overt role in zebrafish 
5.6.2.1 Prlr.a is not essential for reproduction 
Prl has also been demonstrated to influence fish reproduction (Gorvin 2015). Prl has been 
shown to stimulate oestradiol 17-beta (major female sex hormone) secretion in guppy (Poecilia 
reticulata) oocytes throughout their development (Tan et al. 1988). Prlr mRNA and protein 
appeared in fish gonads of a number of  species, such as Mozambique tilapia (Edery et al. 
1984), Japanese flounder (Higashimoto et al. 2001), Nile tilapia (Sandra et al. 2000), fugu 
(Takifugu rubripes) (Lee, Kaneko & Aida 2006b), goldfish (Tse et al. 2000), and starry 
flounder (Noh, Lim & Kim 2012), with a suggested involvement in spermatogenesis, 
vitellogenesis, and/or ovulation (Whittington & Wilson 2013). In this Chapter, prlr.a mutants 
showed no differences in mating success or fertilization success. This suggests that prlr.a is 
not essential for zebrafish reproduction. 
5.6.2.2 Prlr.a  is not essential for haematopoiesis 
This Chapter also showed that of prlr.a mutants possess no significant differences in definitive 
haematopoiesis compared to wild-type from embryogenesis to adulthood. These results suggest 
that prlr.a is not essential for zebrafish haematopoiesis.  
5.6.3 Prl signalling in zebrafish 
Binding of PRL to PRLR causes dimerization that induces the phosphorylation of intracellular 
JAK2  that regulates the activation of STAT5 proteins and other signalling pathways, such as 
the mitogen-activated protein kinase (MAPK) and PI3-kinase (PI3K) pathways to mediate 
effects on cell survival, differentiation, and proliferation (Han et al. 1997). In this Chapter, a 
defect in bone formation was observed in prlr.a mutant juveniles as well as stat5.1 mutant 
juveniles to a lesser extent and stat5.2 mutants juveniles to a minor extent. This result suggested 
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that Prl likely signals via Prlr.a to exert its effect on bone formation, largely mediated by Stat5.1 
but with a role for Stat5.2 and other pathways (Figure 5.11 A). In the case of swim bladder 
inflation the prlr.a mutant juveniles showed no defects, but these were observed at a low level 
in stat5.2 mutants and even higher in stat5.1/stat5.2 double mutants. This suggests no direct 
involvement of Prlr.a in Prl-mediated swim bladder inflation signalling, suggesting Prlr.b 
might have a role here, with Stat5.2 and to a lesser extent Stat5.1 mediating this along with 
other pathways (Figure 5.11 B).  
5.6.4 Gene duplication of Prlr 
Continuously during evolution, the duplication of genes and indeed entire genomes has 
occurred providing the possibility for substantial function innovation. Two whole genome 
duplications greatly increased genetic diversity in vertebrates, with a third round of whole 
genome duplication that occurred in ray-finned enhancing this further (Meyer & Schartl 1999). 
Among the duplicated genes many of them have been converted into either pseudogenes or 
‘junk’ DNA, however, many others are involved in either the splitting of function, or in 
facilitating new functions during development (Anderson et al. 1995; Pink et al. 2011). Indeed 
the increased genetic complexity of ray-finned fish has been suggested to underpin their 
evolutionary success and diversity (Smith & Gregory 2009). Amongst cytokine receptor 
signalling components, two paralogues exist for genes encoding cytokines, including Lep 
(lep.a, lep.b) (Gorissen et al. 2009), Prl (prl.a, prl.b) (Huang et al. 2009), Csf3 (csf3.a, csf3.b) 
(Oltova, Svoboda & Bartunek 2018), Epo (epo.a, epo.b) (Oltova, Svoboda & Bartunek 2018), 
Kitlg (Kitlga, Kitlgb) (Oltova, Svoboda & Bartunek 2018), Csf1 (csf1.a, csf1.b) (Wang et al. 
2008); cytokine receptors, such as Prlr (prlr.a, prlr.b) (Liongue & Ward 2007), Ghr (ghr.a, 
ghr.b) (Di Prinzio et al. 2010), Lifr (lifr.a, lifr.b) (Liongue & Ward 2007; Ogai et al. 2014) , 
Clf1 (clf1.a, clf1.b) (Liongue & Ward 2007) and Il-12p40 (il-12p40.a, il-12p40.b) (Liongue & 
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Ward 2007), as well as Jak2 (jak2a, jak2b) (Oates et al. 1999a), Stat1 (stat1a, stat1b) (Oates et 
al. 1999b) and Stat5 (stat5.1, stat5.2) (Lewis & Ward 2004). 
Ablation of zebrafish Prl.a has been shown to affect swim bladder formation, survival and bone 
formation that could be rescued by high calcium (Shu et al. 2016). This Chapter revealed that 
ablation of Prlr.a had no effect on swim bladder formation or survival, but resulted in defective 
bone formation. Bone formation was also affected by ablation of Stat5.1 and to a lesser extent 
of Stat5.2. In contrast, swim bladder inflation was affected by Stat5.2 ablation and even more 
so when Stat5.1 was ablated in concert. These results suggest that Prl.a likely signals via Prlr.a 
to exert its effect on bone formation, largely mediated by Stat5.1 but with a role for Stat5.2 and 
other pathways. However, there appears to be no direct involvement of Prlr.a in Prl.a-mediated 
swim bladder inflation signalling, suggesting Prlr.b might have a role here, with Stat5.2 and to 























Figure 5.1: Generation of prlr.a mutant zebrafish using TALENs. 
 
A. Schematic representation of the zebrafish Prlr.a protein, consisting of an extracellular region 
comprising of a cytokine receptor homology domain (CHD) with conserved cysteine residues 
(thin lines) and WSXWS motif (thick line), a transmembrane sequence (black box) and 
intracellular region containing conserved Box 1 and Box 2 motifs (green boxes). The relative 
position of the coding region targeted is shown with a pink arrow.  
B-C. A portion of the zebrafish prlr.a gene showing relevant exons (numbered brown boxes) 
and introns (solid lines) along with sequencing primers (black arrows; F: forward and R: 
reverse) (B). Nucleotide sequences targeted by the TALEN showing bases interacting with 
individual TAL sequences (coloured ovals), the intervening sequence cleaved by the paired 
FokI endonucleases, and BamHI restriction sequences (green) (GGATCC) indicated.  
D. Sanger sequencing traces of homozygous wild-type prlr.awt/wt (wt/wt), and mutant 
prlr.amdu16/mdu16 (mdu16/mdu16) and prlr.amdu17/mdu17 (mdu17/mdu17) alleles with their 
respective translations shown below in black text. The mdu16 allele represents a combined 4 
bp deletion (orange dotted) and 2 bp insertion (orange solid box) while the mdu17 allele 
represents a combined 3 bp deletion (purple dotted box) and 4 bp insertion (purple solid box), 
both of which introduce a stop codon that truncates the encoded protein.  


















Figure 5.2: Effect of prlr.a mutation on the development and growth of juvenile and 
adult zebrafish. 
Images of representative homozygous prlr.awt/wt (wt/wt) and prlr.amdu16/mdu16 (mdu16/mdu16) 
juveniles at 12 dpf (A, B) and adult fish at 4 months post fertilization (C-F). (n = 20, repeated 
3 times).  
  




                                                                                 Chapter Five: Prlr.a function in zebrafish 
152 
Figure 5.3: Effect of prlr.a mutation on the size of juveniles and length, weight and BMI 
of adult zebrafish. 
 
A-B. Quantitation of jaw to head length (A) and total body length (B) of prlr.awt/wt  (wt/wt) 
(nevy blue) and prlr.amdu16/mdu16 (mdu16/mdu16) (peach) with mean and SEM shown in red and 
statistical significance indicated (ns = not significant). (n=20, repeated 2 times). 
C-H. Assessment of individual adult male (C-E) and female (F-H) of prlr.awt/wt (wt/wt) and 
prlr.amdu16/mdu16 (mdu16/mdu16) were assessed for length (C, F), weight (D, G) and calculated 
BMI (E, H) with mean and SEM shown in red and level of significance indicated (ns = not 
significant). (n = 5 -10, repeated 3 times).  
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Figure 5.4: Effect of prlr.a mutation on survival and fecundity of adult zebrafish. 
 
A. Relative survival of prlr.awt/wt (wt/wt), prlr.amdu16/mdu16 (mdu16/mdu16) and prlr.amdu17/mdu17( 
mdu17/mdu17)  fish displayed as a Kaplan-Meier plot with statistical significance indicated (ns 
= not significant). (n = 20, repeated 3 times). 
B-C. Fecundity of prlr.awt/wt (wt/wt), prlr.amdu16/mdu16 (mdu16/mdu16) and prlr.amdu17/mdu17 ( 
mdu17/mdu17)  assessed by mating success represented as percentage (%) and fertilization 
success as percentage of fertilized eggs with mean and SEM shown in red and statistical 
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Figure 5.5: Effect of prlr.a mutation on survival of embryos in fresh water. 
 
The relative survival rate of  prlr.awt/wt (nevy blue),  prlr.amdu16/mdu16 (peach), prlr.amdu17/mdu17 
(sky blue), stat5.1mdu22/mdu22 (brown), stat5.2mdu23/mdu23 (light green) and stat5mdu22/22&mdu23/23  
(grey) presented as a Kaplan-Meier plot with statistical significance indicated (ns = not 
significant). (n = 20, repeated 3 times).  
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Figure 5.6: Effect of prlr.a mutation on swim bladder inflation. 
 
A-L. Representative images of prlr.awt/wt (A, B), prlr.amdu16/mdu16 (C, D), prlr.amdu17/mdu17(E, F), 
stat5.1mdu22/mdu22 (G, H), stat5.2mdu23/mdu23 (I, J) and stat5mdu22/22+mdu23/23 (K, L) juveniles at 9 dpf. 
The left column shows juveniles with normal swim bladder inflation (A, C, E, G, I, K) and the 
right column shows juveniles with defective swim bladder inflation (B, D, F, H, J, L). 
M. Graphical representation of the percentage of juveniles with normal and defective swim 
bladder for each alleles (n = 100, repeated 3 times) with mean and SEM shown in red and 
statistical significance indicated (**** p<0.0001, ** p<0.001). 
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Figure 5.7: Effect of prlr.a mutation on jaw formation of zebrafish juveniles. 
 
A-O. Representative images of both prlr.awt/wt (A-C), prlr.amdu16/mdu16 (D-F), prlr.amdu17/mdu17 
(G-I), stat5.1mdu22/mdu22 (J-L) and stat5.2mdu23/mdu23 (M-O) juveniles stained with alizarin red and 
jaw indicated with black arrow. (Abbreviation: FW: Fresh water; HWLC: Hypotonic water 
with low conc. Ca2+; HWHC: Hypotonic water with high conc. Ca2+). 
P-U. Relative jaw formation, showing scoring schema (P-T) and quantitation (U) for 
individual, with the mean and SEM shown in red and level of statistical significance indicated 
(**** p<0.0001, ** p<0.01, * p<0.05 and ns = not significant). (n = 20, repeated 3 times).
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Figure 5.8: Effect of prlr.a mutation on bone formation of juvenile. 
 
A-O. Representative images of both prlr.awt/wt (A-C), prlr.amdu16/mdu16 (D-F), prlr.amdu17/mdu17 
(G-I), stat5.1mdu22/mdu22 (J-L), and stat5.2mdu23/mdu23 (M-O) juveniles stained with alizarin red. 
(Abbreviation: FW: Fresh water, HWLC: Hypotonic water with low conc. Ca2+, HWHC: 
Hypotonic water with high conc. Ca2+). 
P-X. Relative bone formation, showing scoring schema (P-W) and quantitation (X) for 
individual, with the mean and SEM shown in red and level of statistical significance indicated 
(**** p<0.0001, and ns = not significant). (n = 20, repeated 3 times). 
 
  






                                                                                 Chapter Five: Prlr.a function in zebrafish 
164 
 
Figure 5.9: Effect of prlr.a mutation on definitive haematopoiesis. 
 
A-L. Homozygous prlr.awt/wt (wt/wt), and prlr.amdu16/mdu16 (mdu16/mdu16) embryos were 
subjected to WISH with lcp1 (A, B), mpo (D, E), hbbe (G, H) and rag1 (J, K) at 5 dpf. The 
number of lcp1+(C), and mpo+ (F) cells and the area of staining for hbbe (I) and rag1 (L) was 
determined for individual embryos with mean and SEM shown in red and statistical 
significance indicated (ns = not significant). (n = 20, repeated 2 times).  
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Figure 5.10: Effect of prlr.a mutation on adult haematopoiesis. 
 
A-C. Homozygous prlr.awt/wt  (wt/wt) and prlr.amdu16/mdu16  ( mdu16/mdu16)  adult fish were 
analysed for differential counts of individual cell lineages in blood (A), kidney (B) and spleen 
(C) with mean and SEM and statistical significance indicated (ns = not significant). (n = 4, 
repeated 3 times).  
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Figure 5.11: Potential pathways involved in bone formation and swim bladder inflation. 
Proposed signaling downstream of Prl mediating bone formation (A) and swim bladder 
inflation (B).  
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6 Chapter Six: Discussion  




Cell-to-cell communication mediated by cytokines plays many vital roles in multicellular 
organisms. In higher vertebrates such as humans and zebrafish, cytokine receptor (CytoR) 
signaling represents a complex and versatile network that is particularly crucial in the blood 
and immune systems (Liongue, Sertori & Ward 2016). Understanding of how the entire 
CytoR/JAK/STAT/SOCS pathway evolved and then expanded to mediate both conserved and 
specialist functions is limited. To address this point, this thesis focused on three cytokine 
receptors of the Class I cytokine receptor family that appeared at different stages of evolution 
and with different features. CRLF3 has a long evolutionary history and is poorly understood, 
LEPR is found across higher vertebrates, while the PRLR paralogues are fish specific, with 
PRL having very distinct functions in mammals compared to fish. Therefore, this thesis aimed 
to investigate the evolution of CRLF3 and its function in vertebrates; to determine whether 
LEPR has a conserved metabolic function in fish; and, to understand the role of a PRLR 
paralogue in a non-mammalian species. 
6.2 Cytokine receptor evolution 
 
6.2.1 Origins of cytokine receptor signalling 
Cytokine receptor signaling requires the sequential activation of several components. 
Interrogation of genomes from extant species over a large evolutionary history has provided 
clues as to how this pathway was completed (Boulay, O'Shea & Paul 2003). Before the 
divergence of porifera, exemplified by the present day Amphimedon queenslandica, only one 
component of the cytokine receptor signaling pathway was present in metazoa, being a single 
STAT protein (Figure 6.1) (Liongue et al. 2012). However, a JAK protein appeared before the 
divergence of porifera, as did two SOCS proteins: one with higher similarity to 
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SOCS1/2/3/CISH, and other to SOCS6/7 (Liongue & Ward 2013). Although JAK, STAT and 
SOCS components were present at the time of porifera divergence (Liongue & Ward 2013), 
there was no evidence for functional cytokine receptor signaling (Liongue, Sertori & Ward 
2016).  
In Chapter 3, bioinformatic interrogation of genomic databases identified a protein with a 
cytokine receptor homology domain (CHD) in the present-day placozoan, Trichoplax 
adhareans, which resembled CRLF3. However, given that the CRLF3 protein lacks both a 
transmembrane and intracellular domain it is unlikely to be functional in terms of signaling. 
Only in extant invertebrates is a bone fide CytoR present, such as in the fruitfly, Drosophila 
melanogaster, with its class I GP130-related Dome containing a cytokine receptor homology 
domain (CHD) and three extracellular fibronectin-type-III domains (FBNIII) as well as 
transmembrane sequence and intracellular domain. This has been confirmed to be associated 
with a JAK (encoded by hopscotch) to activate a STAT (encoded by stat92E) and be regulated 
by a SOCS (encoded by socs36E) (Brown, Hu & Hombria 2001; Harrison et al. 1998).   
Following the establishment of the CytoR/JAK/STAT/SOCS signaling pathway early in the 
divergence of protostomes, the next major event was the emergence of members of the class II 
CytoR along with the expansion of the STAT protein which occurred before the divergence of 
urochordata (Liongue, Sertori & Ward 2016) (Figure 6.1). Thus the extant urochordata, sea 
squirt, has one class I, two class II, one JAK (Leu et al. 2000), two STAT (Wang & Levy 2012), 
and three SOCS (Liongue, Sertori & Ward 2016; Liongue & Ward 2007) proteins. Therefore, 
during early vertebrate evolution prior to the emergence of osteichtyes, the CytoR signaling 
had established a signaling niche  (Liongue, Sertori & Ward 2016).  
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6.2.2 Expansion and diversification of the cytokine receptor signalling 
Early vertebrate evolution represents a period of significant innovation in organism 
morphology and specialization of cellular functions, with one such innovation being the 
development of complex blood and immune systems (Liongue, Sertori & Ward 2016; Litman, 
Rast & Fugmann 2010). During this time there were two whole genome duplications (WGD), 
which appear to have generated much of the necessary genetic substrate required (Meyer & 
Schartl 1999). Indeed, the first and second WGD round significantly increased the number of 
cytokine receptor signaling components, although the increase in CytoR diversity was higher 
than what would be expected if it were wholly reliant on the two WGD events, suggesting other 
processes were also involved (Liongue & Ward 2007). This collectively led to the 
establishment of a set of “core receptors” and downstream components at the divergence of 
gnathostomes that control multiple facets of growth and homeostasis, including immunity and 
haematopoiesis (Boulay, O'Shea & Paul 2003; Liongue, Sertori & Ward 2016). This includes 
twenty-nine class I, twelve class II, four JAK, six STAT, two SHP and eight SOCS in this core 
cytokine receptor signaling pathway (Figure 6.1) (Liongue et al. 2012; Liongue & Ward 2013; 
Wang & Levy 2012). 
There has been only limited further expansion in the human and zebrafish lineages, despite an 
additional WGD in teleost fish (Meyer & Schartl 1999). Zebrafish have thirty-six class I and 
fourteen class II CytoR, five JAK, eight STAT, and twelve SOCS proteins whereas humans 
have thirty-three class I and twelve class II CytoR, four JAK, seven STAT, and eight SOCS 
proteins (Figure 6.1) (Leu et al. 2000; Liongue et al. 2012; Wang & Levy 2012). This has likely 
contributed to the rise of more sophisticated immune systems (Liongue, Sertori & Ward 2016).   
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6.2.3 Conservation vs. specialization of cytokine receptor functions 
Higher vertebrates have a similar number of cytokine receptors, but are they conserved or have 
they developed specialist functions? The functions of many cytokine receptors have been 
shown to be similar between zebrafish and mammals (Iwanami et al. 2011; Liongue et al. 2009; 
McMenamin et al. 2013; Michel et al. 2016). For example, growth hormone (GH) deficient 
humans have short stature and are mildly obese (Procter, Phillips & Cooper 1998), while 
inactivation of the Gh gene in mice leads to reduced post-natal growth and obesity (Oberbauer 
et al. 1997; Wabitsch 2000). Similar features were also observed in the gh1 mutant zebrafish, 
vizzini, which exhibited increased addition of adipose tissue and a severe defect in somatic 
growth (McMenamin et al. 2013). The granulocyte colony-stimulating factor receptor (Gcsfr-/-
) knockout mice are neutropenic (Richards et al. 2003). Morpholino-mediated knockdown of 
zebrafish gcsfr also reduced neutrophil numbers (Liongue et al. 2009). In humans, deficiency 
of IL-7Rα prevents T cell development (Roifman et al. 2000). Similarly, il7r-/- zebrafish 
embryos exhibited severely impaired T lymphopoiesis (Cai et al. 2018). Finally, EpoR is vital 
for mouse definitive haematopoiesis (Lin et al. 1996), while zebrafish epor morphants 
demonstrated complete impairment of definitive erythropoiesis (Paffett-Lugassy et al. 2007).  
6.2.4 Functional analysis of cytokine receptor exemplars 
6.2.4.1 Crlf3 
Chapter 3 revealed that zebrafish crlf3 mutants showed normal development, growth and 
reproduction. Available information about Crlf3 knockout mice does not indicate any major 
issues with their development or reproduction, but describes them to be smaller in size (MGI 
2018). This suggests that CRLF3 may have a role in growth that is potentially specific for 
mammals. 
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Chapter 3 identified a key role for Crlf3 in zebrafish primitive haematopoiesis. The crlf3 mutant 
embryos showed reduced ikzf1+ haematopoietic progenitor cells along with spi1+ myeloid and 
gata1+erythroid progenitors, while no significant differences were observed in scl+ 
haemangioblasts and fli1+ vascular precursor cells. Together these results suggest that crlf3 acts 
at the level of haematopoietic progenitor cells, which impacts on both erythroid and myeloid 
lineages. Primative haematopoiesis has not been explored in Crlf3 knock out mouse (Smith et 
al. 2017). 
In definitive haematopoiesis, crlf3 mutants showed a decrease in cmyb+ haematopoietic stem 
cells but an increase in ikzf1+ lymphoid progenitors. They also possessed decreased hbbe+ 
erythrocytes, mpl+ thrombocytes, lcp1+ monocytes and mpo+ neutrophils. These results suggest 
crlf3 acts as a positive regulator at the level of HSCs during definitive haematopoiesis, with 
the reduced HSCs ultimately leading to decreases in most other haematopoietic cell lineages. 
It is also possible that crlf3 separately acts as a negative regulator for lymphoid progenitors, 
which impacts on mature lymphoid cells.  
The blood of crlf3 mutant adult fish also showed a significant increase in lymphocytes and 
decrease in neutrophils and thrombocytes with the kidney also showing increased lymphocytes, 
monocytes and eosinophils but a reduction of erythrocytes and neutrophils. These is therefore 
a consistent trend for increased lymphocytes and decreased neutrophils and thrombocytes 
across the life-course. However, the adult showed additional changes, suggesting a more 
complex role. The Crlf3 mouse mutant exhibited reduced thrombocytes, suggesting this aspect, 
at least, is conserved, but also possessed high haemoglobulin levels which is different to 
zebrafish (Smith et al. 2017).  
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6.2.4.2 Lepr 
In mammals, leptin (LEP) and leptin receptor (LEPR) play key roles in food intake and energy 
metabolism, with loss of LEPR functions leading to impaired control of appetite and 
metabolism (Kuo et al. 2005). Chapter 4 showed that lepr mutants exhibited normal growth 
and development that continued into adulthood, and normal fecundity and survival. Adult lepr 
mutants also possessed normal weight and BMI, liver, fat and fasting glucose. Similarly, 
previous studies on zebrafish lepr mutant showed no differences in development and growth in 
both embryonic and adult stage and fecundity as well as weight and BMI (Michel et al. 2016). 
Analysis of lepr medaka mutant showed a transient increase in body weight at post-juvenile 
stage but was not consistent in adults (Chisada et al. 2014). In contrast, Lepob/ob and Leprdb/db 
mice have three times more weight than normal mice under the normal feeding conditions  
(Maffei et al. 1995), while enlarged fatty livers were observed in the Leprdb/db mice (Cohen et 
al. 2001). These results may be explained by differences in mass-specific metabolic rate 
between rodents and fish. Rodents bear a high mass-specific metabolic rate and can only fast 
for hours while ectothermic fishes can fast for months (Londraville et al. 2014). Mutation in 
the leptin receptor in rodents slows down the metabolic process which causes increased weight 
in mutants compared to wild-type animals. However, mutation of leptin receptor may have less 
effect on fish appetite and metabolism. 
Following overfeeding an increased BMI and blood glucose was observed in the lepr mutants 
compared to wild-type fish. One possibility is that lepr mutants may be less physically active 
compared to wild-type fish following overfeeding or they consumed more food. Another 
potential explanation is that the lepr mutants developed insulin resistence due to overfeeding 
which increased glucose levels, like the leprdb/db mice, which show hyperglycaemia because of 
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insulin resistance (Aronoff et al. 2004). Increased weight following over-feeding was also 
observed in previously studied lepr mutant (Michel et al. 2016). 
Physiological feedback loops are important in maintaining homeostasis. However, there are 
differences in the feedback loop that regulate the food intake and energy balance between 
species (Schmidt-Nielsen 1997). The intake of food is typically related to energy requirements 
but many factors such as physical conditions, environmental temperature, stress, age, weight 
and digestion system also influences food intake (Drewnowski & Shultz 2001; French, Story 
& Jeffery 2001; Yau & Potenza 2013). The dominant mechanisms that control the food intake 
depend on physiological state which is highly variable among ruminants and other animals 
(Allen 2014). The studies in Chapter 4 revealed no effects of Lepr mutation on zebrafish 
development and metabolism. In contrast, the equivalent Lepr knockout (db/db) mice are 
overweight with diabetics and other metabolic problems (Aronoff et al. 2004; Maffei et al. 
1995), which clearly indicates different physiological systems operating in fish and mammals. 
6.2.4.3 Prlr.a 
Chapter 5 revealed that prlr.a mutants showed normal development, length, weight, BMI and 
survival. Prlr-/- mice showed defect in mammary gland development but no changes in overall 
development or growth (Gorvin 2015; Kelly et al. 1991).  This suggests there is no essential 
role for PRL/PRLR on vertebrate development, growth and survival.  
The prlr.a mutants also showed normal fecundity. In contrast, female Prlr-/- mice were sterile 
due to reduced egg development, ovulation and impaired blastocyte implantation (Ormandy et 
al. 1997). Moreover, half of Prlr-/- females have alternations in estrous cyclicity. In the case of 
male Prlr-/- mice, as half also had fertility problems (Ormandy et al. 1997). One possibility is 
to the Prlr.b may be involved in signalling required for fecundity in zebrafish rather than Prlr.a. 
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Chapter 5 also showed that prlr.a mutants had defective in bone formation similar to that 
observed in prl-/- zebrafish (Shu et al. 2016). Prlr-/- mice also showed decrease in bone 
formation rate and bone mineral density suggesting a conserved role in bone biology (Welniak, 
Richards & Murphy 2001).  
The prlr.a mutant showed no significant changes in definitive haematopoiesis which continued 
into adulthood.  Prlr-/- mice also demonstrated no differences in thymic or splenic cellularity 
or the composition of the lymphocyte subsets present in bone marrow, thymus or the spleen or 
lymph nodes compared with wild-type (Dogusan et al. 2000). However, prolactin injection 
influenced the successful engraftment and proliferation of human lymphoid cells in SCID mice 
(Murphy, Taub & Longo 1996; Richards & Murphy 2000). This suggests PRL/PRLR has no 
essential function in haematopoietic cells, but it may act in certain settings to influence these 
cells. 
In Chapter 5, only the Prlr.a single knockout was studied, revealing no effect of Prlr.a ablation 
in the growth and development of zebrafish with only minor impacts on bone formation. This 
might be for the overlapping actions of other cytokines due to redundancy. This is particularly 
likely in this case, since GH and PRL utilize very similar receptors that signal via largely 
overlapping pathways, including the JAK2-STAT5 pathway (Chilton & Hewetson 2005). 
Zebrafish also possess duplicates for several of the relevant signaling components (Liongue et 
al. 2012), as well as an additional related cytokine called somatolactin (SL) and its receptor 
(Chen et al. 2011). Therefore, the absence of significant phenotypes following ablation of Prlr.a 
does not necessarily means it plays no role, but simply that other receptors acting redundantly 
are able to compensate for its loss. Of note, Prl.a ablation in zebrafish caused defects in swim 
bladder inflation, growth and survival (Shu et al. 2016) . Thus, Prlr.b or even the somatolactin 
receptor (Slr) might be compensating for Prlr.a such that these phenotypes are not apparent. 
Generation of Prlr.b (and Slr) zebrafish mutants by genome editing tools, as well as double 
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Prlr.a/Prlr.b, Slr/Prlr.a and Slr/Prlr.b mutants would definitively determine if functional 
redundancy exists and/or if each has distinct and specialized roles. 
6.2.5 Cytokine redundancy 
Many cytokines have overlapping actions commonly known as redundancy. This redundancy 
can be due to similar cellular distributions of specific cytokine receptors, sharing of 
downstream signaling pathways, including shared receptor components (Ozaki & Leonard 
2002), which is further exacerbated by gene duplication events. For example, precursor cells 
express many receptors, such as the common myeloid progenitors, which express TPO-R, GM-
CSFR and G-CSFR (Becher, Tugues & Greter 2016; Edvardsson, Dykes & Olofsson 2006; 
Tsuji & Ebihara 2001). In addition, the common beta chain (βc) is shared by GM-CSFR, IL-
3R and IL-5R, with GP130 shared by CNTFR, LIFR, OSMR, IL-6R and IL-11R (Rath & 
Rentmeister 2015). Furthermore, human IL-4, murine IL-3 and human OSM can signal via 
more than one receptor (Ozaki & Leonard 2002). With respect to gene duplications, zebrafish 
Csf3.a and Csf3.b have both been shown to function in embryonic myelopoiesis (Stachura et 
al. 2013). The approach used in this thesis of examining single gene mutants generated by 
TALENs and/or CRISPR/Cas9 may be affected by redundancy. Such redundancy is best 
investigated through the generation of lines in which multiple genes are mutated and comparing 
them to single gene mutants. 
6.2.6 Direct and indirect contribution of cytokine receptors 
Cytokines participate in cell-cell communication particularly involving blood and immune 
cells (Haddad 2002). Through the binding of specific receptors expressed on target cells, these 
cytokines elicit signals that lead to direct impacts on the functions and phenotypes of those 
cells. In Chapter 3, crlf3 was shown to have strong expression at the site of embryonic blood 
and immune cell development with crlf3 ablation impacting on blood and immune cell 
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phenotypes, suggesting a direct effect of crlf3 in zebrafish haematopoiesis. However, cytokines 
can also have indirect effects. For example, Lepr is expressed in the brain, with its activation 
resulting in changes in the levels of key molecules involved in food intake, such as NPY and 
AgRP (Bjorbæk & Kahn 2004; Elias et al. 1999). However, the changes in food intake result 
in impacts on metabolism that indirectly affects other tissue, such as adipose tissue mass (Elias 
et al. 1999; Prokop et al. 2012). Therefore, the Lepr can be said to have a direct effect on factors 
regulating food intake, but an indirect effect on adiposity (Elias et al. 1999). In zebrafish, 
expression of leptin receptor (lepr) was demonstrated to first appear in the notochord during 
embryogenesis and in trunk muscles and gut (Liu et al. 2010). In both larval and adult zebrafish, 
lepr was expressed in the hindbrain as well as other brain regions, such as the hypothalamic 
lateral tuberal nucleus, and also several adult tissues, including muscle, liver, and gonads (Liu 
et al. 2010). In this thesis, visual observation and analysis of fish length, weight and BMI and 
liver as well as mating and fertilization success indicated no obvious direct effects for Lepr on 
muscle, liver and gonads. In addition, prlr.a expression was observed in embryonic pro-nephric 
duct  and pancreas as well as olfactory organs, brain, eyes, intestines, ovaries and spleen of 
adults (Kelly et al. 1991). The lack of overt developmental defects in Prlr.a mutant zebrafish 
throughout the lifespan suggests no direct effects for Prlr.a at least in eyes and ovaries. More 
work is required to pinpoint the direct (and indirect) roles for Lepr and Prlr.a in zebrafish. 
6.2.7 TALEN and CRISPR-CAS9 
Target sites for TALENs can be designed using online tools including the TAL Effector 
Nucleotide Targeter 2.0 and encoding sequences that were synthesized by commercial 
suppliers. TALEN can also be constructed by kits named as the so-called ‘Golden-gate’ 
assembly system (Welker et al. 2016). Both TALEN pairs are introduced through the encoding 
mRNAs which can generate mutants (Bedell et al. 2012) with up to 98.5% efficiency (Dahlem 
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et al. 2012). TALENs are more reliable and efficient than zinc finger nucleases, with greater 
target specificity that leads to the reduction of off-target mutation (Dahlem et al. 2012). In 
target sequence, the requirements of T before the 5’- end limits the selection of TALEN 
nuclease sites (Nemudryi et al. 2014).This limitation can be overcome by selecting  mutants of 
TALEN N-terminal domain that bind to A, G, or C (Lamb, Mercer & Barbas III 2013). For 
CRISPR-Cas9, a single guide RNA (sgRNA) specific for a target site can be designed using 
ZiFiT Targeter online software (Hwang et al. 2013) and sequence for cloning is ordered as an 
oligonucleotide and in vitro transcription. Guide RNA is injected into the zebrafish embryos 
with mRNA encoding Cas9 or Cas9 protein. The main advantages of CRISPR-Cas9 genome 
editing is their high specificity and efficiency as well as the ease with which they can be 
customized, such as to generate tissue-specific knockouts (Jing et al. 2015), or for multiplexing 
to allow targeting of more than one gene or the locations of a gene simultaneously (Jao, Wente 
& Chen 2013). However, the limitation of this CRISPR-Cas9 is its incapability to find out 
target sites in all sequences since it is reliant on specific sequence motifs (Hwang et al. 2013).  
Both TALEN and CRISPR-Cas9 genome editing technologies were used to construct crlf3 
mutant zebrafish while only one technology was used for making lepr (CRISPR-Cas9) and 
prlr.a (TALENs) mutants. The screening process revealed a greater mutation efficiency for 
CRISPR-Cas9 compared to TALENs, although both processes generated similar indel 
mutations, and there were no phenotypic differences between the crlf3 mutants generated by 
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6.3 Future direction 
 
6.3.1 Crlf3 
Chapter 3 failed to identify any transmembrane or intracellular domain for Crlf3 suggesting it 
could act as a soluble cytokine receptor. Such receptor forms can facilitate signaling through 
other receptor chains, for example, soluble IL-6 R acts as an IL-6 agonist by binding the ligand 
and activating cellular responses by associating with cell membrane-bound GP130 (Romano 
et al. 1997). Alternatively, they may acts as so-called ‘decoy’ receptors, for instance, IL-1RII 
that acts as an IL-1 antagonist by binding the ligand and preventing it from interacting with 
cell membrane receptors (Mantovani et al. 2001). However, no leader sequence was observed 
reducing the likelihood it is secreted. Localization of proteins is often determined using 
biochemical approaches (Murata et al. 2014) (for examples, western blotting, 
immunoreactivity with antibody), but these are difficult in zebrafish because of its small size 
and paucity of reagents. Taking the advantage of the transparency and ease of genetic 
manipulation of zebrafish, a strategy to knock-in a tag such as GFP to be expressed as fusion 
with Crlf3 would allow the distribution to be examined by fluorescence microscopy, which 
may shed light on its mechanism of action. There are also many genetic, biochemical and 
bioinformatics approaches available to identify interacting proteins that would provide 
invaluable molecular understanding. Genetically, bacterial two hybrid system (B2H) (Dove & 
Hochschild 2004) based on transcription action, the yeast two hybrid systems (Y2H) (Kuroda 
et al. 2006) are commonly used to identify interacting proteins. Biochemically, the modified 
split-ubiquitin technique (Miller et al. 2005a; Obrdlik et al. 2004), Sos recruitment system 
(SRS) (Aronheim et al. 1997) and Ras recruitment system (RRS) (Broder, Katz & Aronheim 
1998) and G-protein-based screening system (Ehrhard et al. 2000) could also be useful. From 
a bioinformatics perspective, several databases, such as the DIP (Database of interacting 
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proteins) (Salwinski et al. 2009; Xenarios & Eisenberg 2001), MIPS (Munich information 
center for protein sequences) (Pagel et al. 2005), and BIND (Biomolecular interaction network 
database) (Bader, Betel & Hogue 2003), allow for potential interactions to be identified on the 
basis of published data sets.  
6.3.2 Lepr 
In Chapter 4, Lepr mutants displayed normal embryonic haematopoiesis. It would be worth 
examining a potential role in ‘stress haematopoiesis’, such as via injection of 
lipopolysaccharide (LPS) or G-CSF (Liongue et al. 2009). However, further roles should be 
investigated G-CSF – especially in metabolism, where zebrafish shows functional conservation 
in adipose biology, lipid metabolism and glucose homeostasis (Zang, Maddison & Chen 2018). 
Zebrafish has two Leptin orthologues, Lep.a and Lep.b. Knockout of Lep.a and Lep.b 
separately through genome editing and subsequent functional analysis would help identify the 
specific role of each, although this first requires the phenotypes caused by Lepr mutation to be 
identified and fully characterized. 
6.3.3 Prlr.a 
In Chapter 5, only the Prlr.a single knockout was studied, revealing no effect of Prlr.a ablation 
in the growth and development of zebrafish with only minor impacts on bone formation. This 
might be for the overlapping actions of other cytokines due to redundancy. This is particularly 
likely in this case, since GH and PRL utilize very similar receptors that signal via largely 
overlapping pathways, including the JAK2-STAT5 pathway (Chilton & Hewetson 2005). 
Zebrafish also possess duplicates for several of the relevant signaling components (Liongue et 
al. 2012), as well as an additional related cytokine called somatolactin (SL) and its receptor 
(Chen et al. 2011). Therefore, the absence of significant phenotypes following ablation of Prlr.a 
does not necessarily means it plays no role, but simply that other receptors acting redundantly 
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are able to compensate for its loss. Of note, Prl.a ablation in zebrafish caused defects in swim 
bladder inflation, growth and survival (Shu et al. 2016) . Thus, Prlr.b or even the somatolactin 
receptor (Slr) might be compensating for Prlr.a such that these phenotypes are not apparent. 
Generation of Prlr.b (and Slr) zebrafish mutants by genome editing tools, as well as double 
Prlr.a/Prlr.b, Slr/Prlr.a and Slr/Prlr.b mutants would definitively determine if functional 
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Figure 6.1: Evolution of cytokine receptor signalling components. 
Schematic representation of the emergence and divergence of CytoR, JAK, STAT and SOCS 
proteins which are represented by the circles (CytoR: purple; light = CRLF3, dark = Class I 
and darker = Class II, JAK: yellow, STAT: blue, SOCS: orange) with the size and number 
reflecting their relative expansion. A time line with key evolutionary events shown, including 
the grey WGD events. The black arrows represents the emergence of Cytor/Jak/Stat signaling 
pathway and its complexity with time.
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